{"library":[{"id":"addiction_federal_marketing","title":"42 CFR Part 2 confidentiality and FTC endorsement rules in addiction marketing (federal)","authority":"42 C.F.R. Part 2 (2024 Final Rule, effective Apr. 16, 2024, compliance required Feb. 16, 2026; OCR enforcement under the Aug. 25, 2025 delegation; civil and criminal penalties now apply; stricter than HIPAA for marketing uses). 16 C.F.R. Part 255 Endorsement Guides, 255.2 (typicality) and 255.5 (material connections). Enforced by HHS OCR and the FTC. 15 U.S.C. 45d (Opioid Addiction Recovery Fraud Prevention Act, 2018): unfair or deceptive acts or practices regarding any SUD treatment service or product are unlawful and treated as FTC rule violations, civil penalty up to $53,088 per violation (eff. Jan. 17, 2025).","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-23","sources":[{"label":"42 C.F.R. Part 2 (eCFR current text)","url":"https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-2","primary":true},{"label":"16 C.F.R. Part 255 Endorsement Guides","url":"https://www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-255","primary":true},{"label":"HHS fact sheet, 42 CFR Part 2 Final Rule (2024)","url":"https://www.hhs.gov/hipaa/for-professionals/regulatory-initiatives/fact-sheet-42-cfr-part-2-final-rule/index.html","primary":false}]},{"id":"addiction_platform_policies","title":"Platform certification requirements for addiction treatment advertising","authority":"Google Ads Healthcare and medicines policy (LegitScript certification required for addiction treatment advertisers since 2018). Meta advertising policies (2019: LegitScript certification plus written permission required). Microsoft Advertising and Nextdoor carry parallel requirements. Requirements cover treatment facilities AND lead generators and referral agencies. Certification timelines typically run 4 to 8 weeks.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":90,"review_method":"human","guard_updated":"2026-07-23","sources":[{"label":"Google Ads Healthcare and medicines policy","url":"https://support.google.com/adspolicy/answer/176031","primary":true},{"label":"Meta advertising standards, addiction treatment","url":"https://transparency.meta.com/policies/ad-standards/","primary":true},{"label":"LegitScript addiction treatment certification","url":"https://www.legitscript.com/service/certification/addiction-treatment/","primary":false}]},{"id":"arizona_addiction_marketing","title":"Arizona addiction treatment patient brokering and sober living home marketing (AZ)","authority":"A.R.S. 44-1522 (Arizona Consumer Fraud Act; unlawful deception, deceptive or unfair acts, false promise, misrepresentation, or concealment of a material fact in connection with the sale or advertisement of merchandise; enforced by the Arizona Attorney General and by private action). A.R.S. 13-3730 (Arizona patient-brokering and anti-kickback statute for sober living homes and substance use disorder treatment facilities; SB 1308, 2025; a tiered felony graded by the value exchanged, a class 3 felony at $1,000 or more, a class 4 felony above $100 and below $1,000, and a class 6 felony at $100 or less; no safe harbor in the statute's text). A.R.S. 36-2062 and 36-2063 (Arizona Department of Health Services sober living home licensure requirement and civil penalty of not more than $1,000 per day).","jurisdiction":"AZ","status":"active","reviewed_date":"2026-07-30","review_interval_days":90,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"A.R.S. 44-1522 (Arizona Consumer Fraud Act, unlawful practices)","url":"https://www.azleg.gov/viewdocument/?docName=https%3A%2F%2Fwww.azleg.gov%2Fars%2F44%2F01522.htm","primary":true},{"label":"A.R.S. 13-3730 (patient brokering; sober living homes and SUD treatment facilities)","url":"https://www.azleg.gov/viewdocument/?docName=https%3A%2F%2Fwww.azleg.gov%2Fars%2F13%2F03730.htm","primary":true},{"label":"A.R.S. 36-2062 (sober living home licensure required)","url":"https://www.azleg.gov/ars/36/02062.htm","primary":true}]},{"id":"arizona_mental_health_marketing","title":"Arizona mental health advertising (A.R.S. 32-3251)","authority":"A.R.S. 32-3251(16)(d) (making any false, fraudulent or deceptive statement connected with the practice of behavioral health, including false or misleading advertising) and 32-3251(16)(c)(iii) (misrepresentation of fact regarding the licensee's skills or the value of any treatment provided or to be provided), which together define unprofessional conduct for every licensee of the Board of Behavioral Health Examiners.","jurisdiction":"AZ","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"A.R.S. 32-3251 (behavioral health, definitions including unprofessional conduct)","url":"https://www.azleg.gov/viewdocument/?docName=https://www.azleg.gov/ars/32/03251.htm","primary":true},{"label":"A.R.S. 32-3281 (behavioral health, disciplinary action)","url":"https://www.azleg.gov/viewdocument/?docName=https://www.azleg.gov/ars/32/03281.htm","primary":false}]},{"id":"california_addiction_marketing","title":"California deceptive addiction treatment marketing and patient brokering (CA)","authority":"Cal. Health and Safety Code 11831.6 (SB 1228; no giving or receiving remuneration or anything of value for referral of a person seeking alcohol or other drug recovery or treatment services; covers licensed facilities, 10-percent-plus owners, employees, registered and certified counselors and licensed professionals, and certified programs and their workers; DHCS may implement via provider bulletins per subd. (b)). HSC 11831.7 (DHCS investigation and sanctions; AOD Code of Conduct (2019) sets a civil penalty up to $2,000 per occurrence plus license or certification suspension or revocation). HSC 11831.9 (SB 1165, amended Stats. 2024 ch. 847 eff. Jan. 1, 2025; false or misleading statements about products, goods, services, or geographical locations, medical treatments, or via deceptive websites). Cal. Bus. and Prof. Code 17500 (false advertising) and 17200 (Unfair Competition Law). Enforced by DHCS and the California Attorney General.","jurisdiction":"CA","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"Cal. HSC 11831.6 (referral remuneration)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=11831.6&lawCode=HSC","primary":true},{"label":"Cal. HSC 11831.7 (DHCS enforcement)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=11831.7&lawCode=HSC","primary":true},{"label":"Cal. HSC 11831.9 (false or misleading marketing; geographic locations)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?sectionNum=11831.9&lawCode=HSC","primary":true}]},{"id":"california_auto_renewal","title":"California Automatic Renewal Law disclosures (Bus. and Prof. Code 17600-17606) (CA)","authority":"Cal. Business and Professions Code 17600 to 17606 (Automatic Renewal Law), as amended by AB 2863 (Schiavo, 2024), signed September 24, 2024, which amended sections 17601 and 17602 and applies to contracts entered into, amended, or extended on or after July 1, 2025 (17602(j)). It is unlawful for a business making an automatic renewal or continuous service offer to a California consumer to fail to present the offer terms clearly and conspicuously before the agreement is fulfilled and in visual proximity to the request for consent (17602(a)(1)), to charge without the consumer's affirmative consent (17602(a)(2), (a)(4)), to fail to provide a retainable acknowledgment with the terms, cancellation policy, and how to cancel (17602(a)(3)), or to fail to let the consumer cancel at will exclusively online (17602(d)(1)). A free trial or promotional price lasting more than 31 days triggers a cancellation notice 3 to 21 days before it ends (17602(b)). Enforced under the Unfair Competition Law.","jurisdiction":"CA","status":"active","reviewed_date":"2026-07-24","review_interval_days":120,"review_method":"human","guard_updated":"2026-07-24","sources":[{"label":"Cal. Bus. and Prof. Code 17602 (automatic renewal duties)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=BPC&sectionNum=17602","primary":true},{"label":"Cal. Bus. and Prof. Code 17601 (definitions)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=BPC&sectionNum=17601","primary":true},{"label":"Cal. Bus. and Prof. Code 17600 (legislative intent)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=BPC&sectionNum=17600","primary":true}]},{"id":"california_mental_health_marketing","title":"California mental health advertising (BPC 651 healing arts)","authority":"Cal. Bus. & Prof. Code 651 (false, fraudulent, misleading or deceptive advertising by healing arts licensees), which binds every person licensed under Division 2 of the Business and Professions Code. That includes psychologists (Ch. 6.6), marriage and family therapists, licensed clinical social workers and licensed professional clinical counselors (Ch. 13 and 14), all of whom are regulated by the Board of Behavioral Sciences or the Board of Psychology. A violation of 651 is a misdemeanor under 651(f) and is independent ground for discipline under Cal. Bus. & Prof. Code 4982 (BBS licensees) and 2960 (psychologists).","jurisdiction":"CA","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"Cal. Bus. & Prof. Code 651 (advertising by healing arts licensees)","url":"https://california.public.law/codes/ca_bus_and_prof_code_section_651","primary":true},{"label":"Cal. Bus. & Prof. Code 651 (official, leginfo)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=BPC&sectionNum=651","primary":true},{"label":"Cal. Bus. & Prof. Code 4982 (BBS unprofessional conduct)","url":"https://california.public.law/codes/ca_bus_and_prof_code_section_4982","primary":false}]},{"id":"california_professional_advertising","title":"California healing arts advertising (BPC 651)","authority":"Cal. Bus. & Prof. Code 651, which makes it unlawful for any person licensed under Division 2 of the Business and Professions Code, the Healing Arts division, to disseminate any public communication containing a false, fraudulent, misleading, or deceptive statement, claim, or image for the purpose of inducing the rendering of professional services. Division 2 covers dentistry (Ch. 4), medicine (Ch. 5), nursing (Ch. 6) and the other healing arts, so the section binds dentists, physicians and the physicians and nurses who deliver aesthetic, longevity and infusion services alike. A violation of 651 is a misdemeanor under 651(f) and is independent ground for board discipline.","jurisdiction":"CA","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"Cal. Bus. & Prof. Code 651 (advertising by healing arts licensees)","url":"https://california.public.law/codes/ca_bus_and_prof_code_section_651","primary":true},{"label":"Cal. Bus. & Prof. Code 651, official California Legislative Information","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=BPC&sectionNum=651","primary":true}]},{"id":"california_prop65_listings","title":"California Proposition 65 e-commerce listing-page warnings for supplements, hemp/CBD, med spa, and longevity products (CA)","authority":"Cal. Health and Safety Code 25249.6 (Safe Drinking Water and Toxic Enforcement Act of 1986: no person in the course of doing business shall knowingly and intentionally expose an individual to a listed chemical without first giving a clear and reasonable warning). Safe-harbor warning regulations at Cal. Code Regs. tit. 27, 25601 to 25603 and 25607.2: warning content at 25603 (long form and short form), methods of transmission including the internet-purchase rule at 25602, general provisions at 25601, and tailored warnings at 25607.2. OEHHA amended the short-form warning (OAL-approved November 26, 2024, effective January 1, 2025): a safe-harbor short-form warning must now name at least one specific listed chemical per applicable hazard endpoint (cancer and/or reproductive toxicity), which was not required before 2025, with a three-year grace period through January 1, 2028 for products already labeled with the old short form. Enforced by the California Attorney General, district and city attorneys, and private enforcers under Health and Safety Code 25249.7.","jurisdiction":"CA","status":"active","reviewed_date":"2026-07-24","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-24","sources":[{"label":"Cal. Health and Safety Code 25249.6 (clear and reasonable warning duty)","url":"https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=HSC&sectionNum=25249.6","primary":true},{"label":"OEHHA, Proposition 65 clear and reasonable warnings, safe-harbor methods and content (27 CCR 25601 to 25603, 25607.2)","url":"https://oehha.ca.gov/proposition-65/crnr/proposition-65-clear-and-reasonable-warnings-safe-harbor-methods-and-content","primary":true},{"label":"OEHHA short-form warning amendment (OAL-approved 2024-11-26, effective 2025-01-01, chemical-name requirement)","url":"https://oehha.ca.gov/proposition-65/crnr/notice-approval-amendments-article-6-clear-and-reasonable-warnings-short-form","primary":true}]},{"id":"can_spam_email","title":"CAN-SPAM deceptive subject and sender (federal, email)","authority":"CAN-SPAM Act, 15 U.S.C. 7704(a)(1) (false or misleading transmission information) and 7704(a)(2) (deceptive subject headings); enforced by the FTC.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-18","review_interval_days":365,"review_method":"human","guard_updated":"2026-07-18","sources":[{"label":"15 U.S.C. 7704 verbatim (govinfo.gov)","url":"https://www.govinfo.gov/content/pkg/USCODE-2022-title15/pdf/USCODE-2022-title15-chap103-sec7704.pdf","primary":true},{"label":"15 U.S.C. 7704 (official code viewer)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section7704&num=0&edition=prelim","primary":true},{"label":"FTC CAN-SPAM Act: A Compliance Guide for Business","url":"https://www.ftc.gov/business-guidance/resources/can-spam-act-compliance-guide-business","primary":true}]},{"id":"can_spam_email_body","title":"CAN-SPAM footer duties: postal address and opt-out (federal, email)","authority":"CAN-SPAM Act, 15 U.S.C. 7704(a)(3) (opt-out mechanism and what may not be required to use it) and 7704(a)(5)(A) (clear and conspicuous opt-out notice and a valid physical postal address of the sender); implementing rule 16 C.F.R. Part 316; enforced by the FTC.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-26","review_interval_days":365,"review_method":"human","guard_updated":"2026-07-26","sources":[{"label":"15 U.S.C. 7704 verbatim (govinfo.gov)","url":"https://www.govinfo.gov/content/pkg/USCODE-2022-title15/pdf/USCODE-2022-title15-chap103-sec7704.pdf","primary":true},{"label":"15 U.S.C. 7704 (official code viewer)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section7704&num=0&edition=prelim","primary":true},{"label":"15 U.S.C. 7702 definitions, including commercial vs transactional or relationship messages","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section7702&num=0&edition=prelim","primary":true}]},{"id":"co_cannabis","title":"Colorado regulated marijuana signage and advertising (MED)","authority":"Colorado Marijuana Enforcement Division (Dept. of Revenue), Colorado Marijuana Rules 1 CCR 212-3, 3-700 Series (Signage and Advertising), Rules 3-705 through 3-755; C.R.S. 44-10-203(3)(a) (statutory advertising mandates).","jurisdiction":"CO","status":"active","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"1 CCR 212-3 Colorado Marijuana Rules (official Secretary of State CCR PDF, current version)","url":"https://www.coloradosos.gov/CCR/GenerateRulePdf.do?ruleVersionId=12351&fileName=1+CCR+212-3","primary":true},{"label":"1 CCR 212-3 Rule 3-705 Advertising General Requirements (LII mirror, drift-check page)","url":"https://www.law.cornell.edu/regulations/colorado/1-CCR-212-3-3-705","primary":true},{"label":"C.R.S. 44-10-203 (state licensing authority rules, advertising mandates at (3)(a))","url":"https://colorado.public.law/statutes/crs_44-10-203","primary":false}]},{"id":"co_nmha_dora","title":"Colorado Natural Medicine advertising (NMHA / DNM)","authority":"CO Dept. of Revenue Natural Medicine Division, 1 CCR 213-1 Rule 3505 (Licensee Marketing); DORA Office of Natural Medicine Licensure, 4 CCR 755-1 Section 7 (Advertising); C.R.S. 12-170-105 and Title 44 Art. 50.","jurisdiction":"CO","status":"active","reviewed_date":"2026-07-29","review_interval_days":120,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"1 CCR 213-1 (DOR Natural Medicine rules, Rule 3505 Licensee Marketing)","url":"https://www.coloradosos.gov/CCR/GenerateRulePdf.do?ruleVersionId=11634&fileName=1+CCR+213-1","primary":true},{"label":"4 CCR 755-1 Sec. 7 Advertising (facilitators)","url":"https://www.law.cornell.edu/regulations/colorado/4-CCR-755-1-7","primary":true},{"label":"C.R.S. 12-170-105 (advertising-standards mandate)","url":"https://law.justia.com/codes/colorado/title-12/business-professions-and-occupations/article-170/section-12-170-105/","primary":true}]},{"id":"colorado_addiction_marketing","title":"Colorado deceptive addiction treatment marketing (CO)","authority":"Colorado Consumer Protection Act, C.R.S. 6-1-105 (deceptive trade practices, including false or misleading advertising) and 6-1-112 (civil penalty up to $20,000 per violation, per consumer or transaction; AG and district attorney enforcement plus private action). 2 CCR 502-1 (Behavioral Health Administration provider rules; SUD treatment providers must be licensed). C.R.S. 12-245-224(1)(q) (professional-discipline referral-remuneration prohibition WITH an express carve-out permitting licensees to pay independent advertising or marketing agents, including per-patient performance compensation). Enforced by the Colorado Attorney General and the Behavioral Health Administration.","jurisdiction":"CO","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"C.R.S. 6-1-105 (deceptive trade practices)","url":"https://colorado.public.law/statutes/crs_6-1-105","primary":true},{"label":"C.R.S. 6-1-112 (CCPA civil penalties)","url":"https://colorado.public.law/statutes/crs_6-1-112","primary":true},{"label":"C.R.S. 12-245-224(1)(q) (referral remuneration carve-out)","url":"https://colorado.public.law/statutes/crs_12-245-224","primary":true}]},{"id":"colorado_mental_health_marketing","title":"Colorado mental health advertising (C.R.S. 12-245-224)","authority":"C.R.S. 12-245-224(1)(c) (a licensee, registrant or certificate holder who has used advertising that is misleading, deceptive or false), part of the prohibited activities of the Mental Health Practice Act, which covers psychologists, clinical social workers, marriage and family therapists, licensed professional counselors and addiction counselors. C.R.S. 6-1-105 reaches the same copy as a deceptive trade practice.","jurisdiction":"CO","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"C.R.S. 12-245-224 (prohibited activities, Mental Health Practice Act)","url":"https://colorado.public.law/statutes/crs_12-245-224","primary":true},{"label":"C.R.S. 6-1-105 (deceptive trade practices)","url":"https://colorado.public.law/statutes/crs_6-1-105","primary":false}]},{"id":"colorado_supplement_advertising","title":"Colorado food and supplement advertising (C.R.S. 25-5-418)","authority":"C.R.S. 25-5-418, the advertising section of Colorado’s food, drug, device and cosmetic law. Subsection (1) deems an advertisement of a food false if it is false or misleading in any particular, and subsection (2) enumerates a list of diseases, including cancer, arthritis, diabetes, arteriosclerosis and appendicitis, that an advertisement may not represent a product as having an effect on. C.R.S. 25-5-402(1) defines advertisement to reach all representations disseminated in any manner for the purpose of inducing a purchase, other than labeling.","jurisdiction":"CO","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"C.R.S. 25-5-418(1) (false advertisement of a food)","url":"https://colorado.public.law/statutes/crs_25-5-418","primary":true},{"label":"C.R.S. 25-5-402 (definition of advertisement)","url":"https://colorado.public.law/statutes/crs_25-5-402","primary":true}]},{"id":"delaware_addiction_marketing","title":"Delaware deceptive addiction treatment marketing (DE)","authority":"Delaware patient-brokering law, 6 Del. C. 2502F (SB 32, 82 Del. Laws c. 202, signed 2019), a civil statute providing that a person may not engage in patient brokering, which reaches offering or paying, soliciting or receiving, and receiving the acceptance or acknowledgment of remuneration to induce a patient referral to a health-care provider or facility, and aiding or abetting that conduct, with a civil penalty up to $10,000 per violation under 6 Del. C. 2505F (a further $10,000 where the victim is an elder or disabled person, each willful day a separate violation) and no criminal grade. The statute is written for all of health care though enacted to target substance-use-disorder patient brokering. Delaware Consumer Fraud Act, 6 Del. C. 2513, supplies the general deceptive-marketing layer. Enforced as a civil matter by the State of Delaware.","jurisdiction":"DE","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"6 Del. C. Chapter 25F, Patient Brokering (2502F prohibition; 2505F civil penalty), SB 32 / 82 Del. Laws c. 202","url":"https://delcode.delaware.gov/title6/c025f/index.html","primary":true},{"label":"6 Del. C. Chapter 25, Subchapter II, Consumer Fraud (2513 prohibition), rendered body","url":"https://delcode.delaware.gov/title6/c025/sc02/index.html","primary":true}]},{"id":"ekra_referral_remuneration","title":"EKRA referral remuneration in marketing copy (federal, criminal)","authority":"Eliminating Kickbacks in Recovery Act, 18 U.S.C. 220. Criminal; applies to all payors including private insurance; covers remuneration for referrals to recovery homes, clinical treatment facilities, and laboratories; up to $200,000 and 10 years imprisonment per occurrence. Enforced by DOJ.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-23","sources":[{"label":"18 U.S.C. 220 (EKRA)","url":"https://www.law.cornell.edu/uscode/text/18/220","primary":true},{"label":"United States v. Schena, No. 23-2989 (9th Cir. 2025)","url":"https://cdn.ca9.uscourts.gov/datastore/opinions/2025/07/11/23-2989.pdf","primary":true},{"label":"DOJ press release, D.N.J. Sept. 15, 2020 guilty pleas","url":"https://www.justice.gov/usao-nj/pr","primary":false}]},{"id":"fl_dental","title":"Florida dental advertising (Board of Dentistry)","authority":"Florida Board of Dentistry, Rule 64B5-4.002 F.A.C. (Advertising and Soliciting by Dentists, amended eff. 2026-04-26) and Rule 64B5-4.003 F.A.C. (Advertisement of Fees and Discounted Services). Statutes: Fla. Stat. 466.019 (Advertising by dentists, as amended by ch. 2024-214), 466.0282 (Specialties), 466.028(1)(d), (jj) (discipline), 456.062 (free/discounted-service advertising statement).","jurisdiction":"FL","status":"active","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"Fla. Stat. 466.019 (Advertising by dentists, 2025 statutes)","url":"https://www.flsenate.gov/Laws/Statutes/2025/466.019","primary":true},{"label":"Fla. Stat. 466.0282 (Specialties)","url":"https://www.flsenate.gov/Laws/Statutes/2025/466.0282","primary":true},{"label":"Fla. Stat. 466.028 (Grounds for disciplinary action; (1)(d), (1)(jj))","url":"https://www.flsenate.gov/Laws/Statutes/2025/466.028","primary":true}]},{"id":"fl_medical_marijuana","title":"Florida MMTC advertising and marketing (DOH approval regime)","authority":"Fla. Stat. 381.986(8)(h) (2025) (MMTC advertising; department approval; public-visibility ban); Florida Department of Health Emergency Rule 64ER25-6, MMTC Advertising and Marketing, effective 12-31-2025; Office of Medical Marijuana Use.","jurisdiction":"FL","status":"active","reviewed_date":"2026-07-28","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-28","sources":[{"label":"Fla. Stat. 381.986 (2025), medical use of marijuana (subsection (8)(h) advertising)","url":"https://www.flsenate.gov/Laws/Statutes/2025/381.986","primary":true},{"label":"Florida DOH Emergency Rule 64ER25-6, MMTC Advertising and Marketing (flrules.org rule page, eff. 12-31-2025)","url":"https://www.flrules.org/gateway/ruleNo.asp?id=64ER25-6","primary":true},{"label":"64ER25-6 full rule text (flrules.org document download)","url":"https://www.flrules.org/gateway/readFile.asp?sid=0&tid=30373142&type=1&file=64ER25-6.doc","primary":true}]},{"id":"florida_addiction_marketing","title":"Florida deceptive addiction treatment marketing and patient brokering (FL)","authority":"Fla. Stat. 397.55 (deceptive marketing prohibition; (1)(c) routes violations to the criminal Patient Brokering Act; other violations are first-degree misdemeanors). Fla. Stat. 817.505 (Patient Brokering Act, criminal; penalty tiers at (4): third-degree felony and $50,000 fine at baseline, second-degree felony and $100,000 for 10 to 19 patients, first-degree felony and $500,000 for 20 or more patients; information-services exception at (3)(i)). Enforced by the Florida Attorney General and state prosecutors.","jurisdiction":"FL","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"Fla. Stat. 397.55","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0300-0399/0397/Sections/0397.55.html","primary":true},{"label":"Fla. Stat. 817.505 (Patient Brokering Act)","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0817/Sections/0817.505.html","primary":true},{"label":"Fla. Stat. 501.605 (Telemarketing Act licensure)","url":"https://www.leg.state.fl.us/statutes/index.cfm?App_mode=Display_Statute&URL=0500-0599/0501/Sections/0501.605.html","primary":true}]},{"id":"florida_ketamine","title":"Florida Board of Medicine advertising (physician-supervised care)","authority":"Florida Board of Medicine, Rule 64B8-11.001 F.A.C. (Advertising); Fla. Stat. 458.331, 456.062, 458.3312. DO-run clinics: Board of Osteopathic Medicine, Rule 64B15-14.001.","jurisdiction":"FL","status":"active","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"Rule 64B8-11.001 F.A.C. (Board of Medicine advertising)","url":"https://flrules.org/gateway/ruleno.asp?id=64B8-11.001","primary":true},{"label":"Rule 64B8-11.001 verbatim text (Cornell LII, through 2020)","url":"https://www.law.cornell.edu/regulations/florida/Fla-Admin-Code-Ann-R-64B8-11-001","primary":false},{"label":"Rule 64B15-14.001 F.A.C. (Board of Osteopathic Medicine advertising)","url":"https://flrules.org/gateway/ruleno.asp?id=64B15-14.001","primary":true}]},{"id":"florida_mental_health_marketing","title":"Florida mental health advertising (Fla. Stat. 456.072, 456.062)","authority":"Fla. Stat. 456.072(1)(a) and (1)(m) (misleading, deceptive or fraudulent representations in or related to the practice of a profession), 456.072(1)(t) (an advertisement for health care services naming the practitioner must identify the type of license held), and 456.062 (advertising free or discounted services). Chapter 456 binds every health profession licensed by the Department of Health, which includes psychologists under chapter 490 and clinical social workers, marriage and family therapists and mental health counselors under chapter 491.","jurisdiction":"FL","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"Fla. Stat. 456.072 (grounds for discipline)","url":"https://www.flsenate.gov/Laws/Statutes/2025/456.072","primary":true},{"label":"Fla. Stat. 456.062 (advertising free or discounted services)","url":"https://www.flsenate.gov/Laws/Statutes/2025/456.062","primary":true},{"label":"Fla. Stat. 491.009 (clinical social work, MFT, mental health counseling discipline)","url":"https://www.flsenate.gov/Laws/Statutes/2025/491.009","primary":false}]},{"id":"florida_professional_advertising","title":"Florida health profession advertising (Fla. Stat. 456.072)","authority":"Fla. Stat. 456.072(1), the grounds for discipline that apply across chapter 456, Health Professions and Occupations: General Provisions. Paragraph (a) reaches making misleading, deceptive, or fraudulent representations in or related to the practice of a profession, paragraph (m) reaches deceptive, untrue, or fraudulent representations or employing a trick or scheme, and paragraph (t) requires that any advertisement for health care services naming the practitioner identify the type of licence the practitioner holds. Fla. Stat. 456.062 carries the free or discounted services notice.","jurisdiction":"FL","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"Fla. Stat. 456.072 (grounds for discipline across the health professions)","url":"https://www.flsenate.gov/Laws/Statutes/2025/456.072","primary":true},{"label":"Fla. Stat. 456.062 (advertisement of free or discounted services)","url":"https://www.flsenate.gov/Laws/Statutes/2025/456.062","primary":true}]},{"id":"florida_supplement_advertising","title":"Florida food and supplement advertising (Fla. Stat. 500.04)","authority":"Fla. Stat. 500.04(5), part of the Florida Food Safety Act, which makes the dissemination of any false advertisement a prohibited act, alongside 500.04(2) on misbranding. The FOOD act is the right one for a dietary supplement: chapter 499 is the Drug, Device and Cosmetic Act and does not reach a product marketed as a food.","jurisdiction":"FL","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"Fla. Stat. 500.04(5) (false advertisement of a food)","url":"https://www.flsenate.gov/Laws/Statutes/2025/500.04","primary":true},{"label":"Fla. Stat. 500.11 (misbranded food)","url":"https://www.flsenate.gov/Laws/Statutes/2025/500.11","primary":true}]},{"id":"ftc_health_claims","title":"FTC deceptive health claims and endorsements (federal, always-on)","authority":"FTC Act Section 5 (15 U.S.C. 45, unfair or deceptive acts) and Section 12 (15 U.S.C. 52, false advertising of food, drugs, devices, services, cosmetics); FTC Health Products Compliance Guidance (Dec. 2022); 16 CFR Part 255 Endorsement Guides (2023 revision); 16 CFR 251.1 (use of the word Free). Enforced by the FTC.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"15 U.S.C. 45 (FTC Act Section 5, official code viewer)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section45&num=0&edition=prelim","primary":true},{"label":"15 U.S.C. 52 (FTC Act Section 12, false advertisements, official code viewer)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title15-section52&num=0&edition=prelim","primary":true},{"label":"FTC Health Products Compliance Guidance (Dec. 2022)","url":"https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance","primary":true}]},{"id":"ftc_video_disclosures","title":"FTC clear-and-conspicuous disclosure in video (federal, video assets)","authority":"FTC Act Section 5 (15 U.S.C. 45); FTC .com Disclosures: How to Make Effective Disclosures in Digital Advertising (Mar. 2013), duration and proximity factors; FTC Health Products Compliance Guidance (Dec. 2022), disclosure adequacy; 16 CFR Part 255 Endorsement Guides (2023 revision), 255.1(b) and 255.2(b). Enforced by the FTC.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":365,"review_method":"human","guard_updated":"2026-07-23","sources":[{"label":"FTC .com Disclosures: How to Make Effective Disclosures in Digital Advertising (2013)","url":"https://www.ftc.gov/business-guidance/resources/com-disclosures-how-make-effective-disclosures-digital-advertising","primary":true},{"label":"FTC Health Products Compliance Guidance (2022)","url":"https://www.ftc.gov/business-guidance/resources/health-products-compliance-guidance","primary":true},{"label":"16 CFR Part 255, Guides Concerning the Use of Endorsements and Testimonials (2023 revision)","url":"https://www.ecfr.gov/current/title-16/chapter-I/subchapter-B/part-255","primary":true}]},{"id":"georgia_addiction_marketing","title":"Georgia deceptive addiction treatment marketing (GA)","authority":"Georgia patient brokering law, O.C.G.A. 26-5-80 (SB 4, 2021, effective July 1, 2021), prohibiting remuneration for substance-use-disorder patient referrals, tiered by patient count (a misdemeanor when the conduct involves fewer than ten patients; a felony at ten or more, up to a $500,000 fine per violation at twenty or more). Georgia Fair Business Practices Act, O.C.G.A. 10-1-390 et seq., core prohibition at 10-1-393(a), interpreted consistently with FTC Act Section 5. O.C.G.A. 26-5-80(c) sets AKS-style safe harbors, including an information-service exemption at (c)(8) conditioned on non-steering, no promises of cure or guarantees of treatment, no transportation, and fair-market fees not based on patient value. Enforced by the Georgia Attorney General.","jurisdiction":"GA","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"O.C.G.A. 26-5-80 (Prohibition on Patient Brokering), SB 4 (2021) signed text","url":"https://gov.georgia.gov/document/2021-signed-legislation/sb-4/download","primary":true},{"label":"O.C.G.A. 10-1-393 (Fair Business Practices Act, unlawful acts)","url":"https://consumer.georgia.gov/consumer-topics/fair-business-practices-act","primary":true},{"label":"Georgia General Assembly SB 4 (2021) bill page","url":"https://www.legis.ga.gov/legislation/58874","primary":true}]},{"id":"hemp_cbd_federal","title":"Federal hemp total-THC redefinition advisory (PL 119-37, effective 2026-11-12) (US)","authority":"Public Law 119-37 (H.R. 5371, 119th Cong.), Division B, Title VII, Section 781, enacted November 12, 2025, effective 365 days after enactment (November 12, 2026). Section 781 amends Section 297A of the Agricultural Marketing Act of 1946 (7 U.S.C. 1639o): it keeps the 0.3 percent plant cap but changes the metric from delta-9 THC to total tetrahydrocannabinols (including tetrahydrocannabinolic acid), and excludes from hemp any final hemp-derived cannabinoid product that exceeds 0.4 milligrams combined total THC per container or that contains cannabinoids not capable of being naturally produced or synthesized or manufactured outside the plant. The Act (7 U.S.C. 1639o note) directs the FDA to publish cannabinoid lists within 90 days of enactment; no implementing lists are published as of drafting. Deceptive hemp or CBD marketing is separately reachable under FTC Act Section 5 (15 U.S.C. 45).","jurisdiction":"US","status":"active","reviewed_date":"2026-07-24","review_interval_days":90,"review_method":"human","guard_updated":"2026-07-24","sources":[{"label":"Public Law 119-37 (H.R. 5371), enacted text (govinfo.gov)","url":"https://www.govinfo.gov/content/pkg/PLAW-119publ37/html/PLAW-119publ37.htm","primary":true},{"label":"Public Law 119-37 landing page (govinfo.gov)","url":"https://www.govinfo.gov/app/details/PLAW-119publ37","primary":true},{"label":"7 U.S.C. 1639o (Agricultural Marketing Act of 1946, Sec. 297A, definition of hemp)","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title7-section1639o&num=0&edition=prelim","primary":true}]},{"id":"hipaa_marketing","title":"HIPAA marketing rule (federal)","authority":"45 CFR 164.501 and 164.508(a)(3)-(4); HHS Office for Civil Rights. 2013 Omnibus (HITECH) final rule.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":365,"review_method":"human","guard_updated":"2026-07-23","sources":[{"label":"45 CFR 164.501 (definition of Marketing and Financial remuneration)","url":"https://www.govinfo.gov/content/pkg/CFR-2023-title45-vol2/pdf/CFR-2023-title45-vol2-sec164-501.pdf","primary":true},{"label":"45 CFR 164.508(a)(3)-(4) (authorization for marketing and sale of PHI)","url":"https://www.govinfo.gov/content/pkg/CFR-2023-title45-vol2/pdf/CFR-2023-title45-vol2-sec164-508.pdf","primary":true},{"label":"HHS OCR Marketing guidance","url":"https://www.hhs.gov/sites/default/files/ocr/privacy/hipaa/understanding/coveredentities/marketing.pdf","primary":true}]},{"id":"kentucky_addiction_marketing","title":"Kentucky prohibition on remuneration for treatment-program referrals (KY)","authority":"KRS 222.429 (Prohibition against solicitation or receipt of remuneration for referrals to treatment programs): (1)(a) no person or provider may knowingly and willfully solicit or receive any remuneration, including but not limited to kickbacks, bribes, or rebates, directly or indirectly, overtly or covertly, in cash or in kind, in return for referring a resident to a treatment program as defined in KRS 222.427; (1)(b) no person or provider may pay or offer any such remuneration either to induce a referral of an individual to a treatment program or in exchange for an individual using the services of that treatment program. Subsection (2) preserves conduct protected under 18 U.S.C. 220(b) (EKRA) and its regulations, and subsection (3) deems any conduct violating 18 U.S.C. 220(b) to violate this section, so the state and federal referral rules move together. A violation is a Class A misdemeanor for each offense, and a Class D felony where the aggregation of value of the benefit received is one thousand dollars ($1,000) or more (KRS 222.429(4)). Created by 2024 Ky. Acts ch. 68, sec. 4 (SB 71), effective July 15, 2024.","jurisdiction":"KY","status":"active","reviewed_date":"2026-08-11","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-11","sources":[{"label":"KRS 222.429, prohibition against remuneration for referrals to treatment programs (Kentucky LRC)","url":"https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=54923","primary":true},{"label":"KRS 222.427, definitions, qualified treatment programs, and the advertising-disclosure rulemaking directive (Kentucky LRC)","url":"https://apps.legislature.ky.gov/law/statutes/statute.aspx?id=54922","primary":true},{"label":"2024 Ky. Acts ch. 68 (SB 71), the enacting chapter","url":"https://apps.legislature.ky.gov/law/acts/24RS/documents/0068.pdf","primary":true}]},{"id":"louisiana_addiction_marketing","title":"Louisiana addiction treatment marketing (LA)","authority":"Louisiana Unfair Trade Practices and Consumer Protection Law, La. R.S. 51:1405(A) (unfair or deceptive acts or practices in trade or commerce declared unlawful; Louisiana Attorney General enforcement plus a private right of action), together with La. R.S. 14:70.5.1 (Act 312 of 2026, HB676, signed May 22 2026), a criminal-only prohibition barring any person from knowingly or intentionally soliciting, offering, paying, or receiving any fee, payment, rebate, commission, or anything of value for the referral of a patient to a residential substance abuse facility, a mental health facility, or a facility licensed for substance use disorder treatment, or urging or marketing the same, with a safe harbor at subsection (B) for fees under a lawful agreement that do not vary by number of patients, duration, level, volume, or nature of services; punishable by imprisonment with or without hard labor up to five years, a fine up to $50,000, or both, plus restitution under C.Cr.P. 883.2. Enforced by Louisiana district attorneys (criminal) and the Louisiana Attorney General (LUTPA).","jurisdiction":"LA","status":"pending_review","reviewed_date":"2026-07-29","review_interval_days":90,"review_method":"ai","guard_updated":null,"sources":[{"label":"La. R.S. 14:70.5.1 (Act 312 of 2026, HB676), enrolled text","url":"https://www.legis.la.gov/Legis/ViewDocument.aspx?d=1473982","primary":true},{"label":"La. R.S. 51:1405(A) (Louisiana Unfair Trade Practices and Consumer Protection Law)","url":"https://www.legis.la.gov/","primary":true}]},{"id":"minnesota_auto_renewal","title":"Minnesota automatic renewal disclosures (Minn. Stat. 325G.57) (MN)","authority":"Minn. Stat. 325G.56 to 325G.62 (indefinite subscription agreements), enacted by 2024 Minnesota Laws chapter 114, article 3, effective January 1, 2025 for contracts entered into, modified, or renewed on or after that date. Section 325G.57 requires a seller making an offer for an indefinite subscription agreement to present the offer terms clearly and conspicuously before the consumer accepts and in visual proximity to the offer (subd. 1); to provide a retainable confirmation with the offer terms, free-trial cancellation information, and termination options that are easy to use, cost-effective, and timely, including an online termination election under 325G.60 (subd. 2); to give clear and conspicuous notice of any material change before it takes effect (subd. 3); to notify the consumer 5 to 30 days before a free trial of more than 30 days ends (subd. 4); and to send at least an annual notice of continuous service (subd. 5). Section 325G.58 bars charging before the agreement is authorized and abusive retention tactics; 325G.61 deems goods sent without affirmative consent an unconditional gift.","jurisdiction":"MN","status":"active","reviewed_date":"2026-07-24","review_interval_days":120,"review_method":"human","guard_updated":"2026-07-24","sources":[{"label":"Minn. Stat. 325G.57 (requirements for automatic renewal or continuous service)","url":"https://www.revisor.mn.gov/statutes/cite/325G.57","primary":true},{"label":"Minn. Stat. 325G.56 (definitions)","url":"https://www.revisor.mn.gov/statutes/cite/325G.56","primary":true},{"label":"Minn. Stat. 325G.60 (termination election, online cancellation)","url":"https://www.revisor.mn.gov/statutes/cite/325G.60","primary":true}]},{"id":"minnesota_hemp_advertising","title":"Minnesota hemp and cannabis advertising (Minn. Stat. 342.64)","authority":"Minn. Stat. 342.64, subd. 1, which prohibits a hemp business, a cannabis business or ANY OTHER PERSON from publishing an advertisement for a hemp-derived consumer product or a lower-potency hemp edible that contains false or misleading statements, unverified health or therapeutic claims, promotion of overconsumption, a depiction of a person under 21 consuming, or an image designed or likely to appeal to individuals under 21. Minn. Stat. 342.63 carries the parallel labeling duties.","jurisdiction":"MN","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"Minn. Stat. 342.64 (advertisement; limitations applicable to all advertisements at subd. 1)","url":"https://www.revisor.mn.gov/statutes/cite/342.64","primary":true},{"label":"Minn. Stat. 342.63 (labeling duties for hemp-derived consumer products)","url":"https://www.revisor.mn.gov/statutes/cite/342.63","primary":true}]},{"id":"minnesota_mental_health_marketing","title":"Minnesota mental health advertising (Minn. Stat. 148.98 code of conduct)","authority":"Minn. Stat. 148.98 (rules of conduct for psychologists), whose code forbids claiming professional qualifications that differ from actual qualifications and misrepresenting affiliations. Minn. Stat. 148B.5301 carries the parallel conduct provisions for licensed professional clinical counselors.","jurisdiction":"MN","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"Minn. Stat. 148.98 (psychology rules of conduct)","url":"https://www.revisor.mn.gov/statutes/cite/148.98","primary":true},{"label":"Minn. Stat. 148B.5301 (LPCC conduct)","url":"https://www.revisor.mn.gov/statutes/cite/148B.5301","primary":false}]},{"id":"nevada_addiction_marketing","title":"Nevada prohibited marketing practices for alcohol and drug treatment (NV)","authority":"NRS 458.112: a provider of treatment for alcohol or substance use disorder, a facility or program operator, and a person providing advertising or marketing services on their behalf may not (1)(a) make a false or misleading statement or provide false or misleading information about the products, goods, services, or geographical locations offered; (1)(b) post or otherwise allow on an Internet website false information, or electronic links, coding, or activation that provides false information; (1)(c) solicit, receive, or attempt to solicit or receive a commission, benefit, bonus, rebate, kickback, or bribe in return for a referral; or (1)(d) enter into a contract with a marketing provider that generates referrals or leads through a call center or web-based presence without clear disclosure informing the prospective patient that the person providing the marketing services represents a specific treatment provider, the identity of that provider, and how any list of treatment providers may be accessed. Subsection (2) excepts state agencies and their contractors. A violation is a misdemeanor (NRS 458.112(3)).","jurisdiction":"NV","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-30","sources":[{"label":"NRS 458.112, unlawful acts relating to marketing of treatment (Nevada Legislature)","url":"https://www.leg.state.nv.us/NRS/NRS-458.html","primary":true},{"label":"NRS Chapter 458, abuse of alcohol and drugs (chapter index)","url":"https://www.leg.state.nv.us/nrs/nrs-458.html","primary":true},{"label":"18 U.S.C. 220, Eliminating Kickbacks in Recovery Act (offering or paying remuneration to induce a referral)","url":"https://www.law.cornell.edu/uscode/text/18/220","primary":true}]},{"id":"new_jersey_addiction_marketing","title":"New Jersey addiction treatment patient brokering and deceptive marketing (NJ)","authority":"N.J.S.A. 2C:40A-6 (patient brokering, as amended by P.L. 2025 c.121 / A3973, signed and effective Aug 11 2025; a third-degree crime carrying a fixed $50,000 criminal fine plus restitution, and a civil penalty up to $20,000 per violation). N.J.S.A. 56:8-230 to 56:8-232 (deceptive substance use disorder treatment marketing, P.L. 2025 c.122 / A3974, six enumerated unlawful practices; civil penalty up to $20,000 per violation under the Penalty Enforcement Law, plus a private right of action and treble damages under the Consumer Fraud Act family). Enforced by the Department of Health as to licensed treatment facilities and clinical laboratories, and by the Division of Consumer Affairs as to recovery residences.","jurisdiction":"NJ","status":"pending_review","reviewed_date":"2026-07-29","review_interval_days":120,"review_method":"ai","guard_updated":null,"sources":[{"label":"N.J.S.A. 2C:40A-6 (patient brokering, P.L. 2025 c.121 / A3973)","url":"https://pub.njleg.gov/Bills/2024/AL25/121_.HTM","primary":true},{"label":"N.J.S.A. 56:8-230 to 56:8-232 (deceptive substance use disorder treatment marketing, P.L. 2025 c.122 / A3974)","url":"https://pub.njleg.gov/Bills/2024/AL25/122_.HTM","primary":true}]},{"id":"new_mexico_addiction_marketing","title":"New Mexico deceptive addiction treatment marketing (NM)","authority":"New Mexico Unfair Practices Act, NMSA 57-12-2(D) (unfair or deceptive trade practices: false or misleading statements KNOWINGLY made in connection with the sale of services) and 57-12-3 (declaring such practices unlawful), enforced by the Attorney General with a civil penalty up to $5,000 per willful violation (57-12-11) and a private treble-damages action for willful violations (57-12-10). Advertising is expressly within trade or commerce under the Act. NMAC Title 7, Chapter 21 (behavioral health provider certification). Enforced by the New Mexico Attorney General and the Health Care Authority behavioral health division.","jurisdiction":"NM","status":"pending_review","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":null,"sources":[{"label":"NMSA 57-12-2 (unfair or deceptive practices)","url":"https://law.justia.com/codes/new-mexico/chapter-57/article-12/section-57-12-2/","primary":true},{"label":"NMSA 57-12-3 (unlawful)","url":"https://law.justia.com/codes/new-mexico/chapter-57/article-12/","primary":true},{"label":"NMSA 57-12-10 (private treble damages)","url":"https://law.justia.com/codes/new-mexico/chapter-57/article-12/section-57-12-10/","primary":true}]},{"id":"new_mexico_psilocybin","title":"New Mexico medical psilocybin (no adopted advertising rules)","authority":"New Mexico Medical Psilocybin Act, SB 219 (2025); NM Department of Health, Center for Medical Cannabis and Psilocybin. No advertising or marketing rule adopted or proposed.","jurisdiction":"NM","status":"not_yet_regulated","reviewed_date":null,"review_interval_days":null,"review_method":null,"guard_updated":null,"sources":[{"label":"New Mexico SB 219, Medical Psilocybin Act (2025) full text","url":"https://www.nmlegis.gov/Sessions/25%20Regular/bills/senate/SB0219.HTML","primary":true},{"label":"NM DOH Medical Psilocybin Program","url":"https://www.nmhealth.org/about/mcpp/mpp/","primary":true},{"label":"NM DOH Rules and Regulations (Title 7 Ch. 35 rulemaking list)","url":"https://www.nmhealth.org/about/asd/cmo/rules","primary":true}]},{"id":"new_york_addiction_marketing","title":"New York deceptive addiction treatment marketing and patient brokering (NY)","authority":"N.Y. Mental Hygiene Law 32.06 (patient-brokering prohibition, both directions; provider includes any entity providing or PURPORTING TO PROVIDE substance use disorder services or operating a certified recovery residence; intentional violation of subdivision 2 or 3 is a misdemeanor as defined in the penal law). N.Y. MHL 32.05 (no SUD services without Commissioner approval or an operating certificate) and 32.21 (fines, suspension, revocation). OASAS Local Services Bulletin, Limitations and Prohibitions on Programs and Practitioners (Aug. 4, 2017). N.Y. General Business Law 349 (deceptive acts, AG enforcement plus private action under 349(h)) and 350 (false advertising). Enforced by OASAS and the New York Attorney General.","jurisdiction":"NY","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"N.Y. Mental Hygiene Law 32.06 (patient brokering)","url":"https://newyork.public.law/laws/n.y._mental_hygiene_law_section_32.06","primary":true},{"label":"N.Y. Mental Hygiene Law 32.05 (operating certificate)","url":"https://newyork.public.law/laws/n.y._mental_hygiene_law_section_32.05","primary":true},{"label":"N.Y. Mental Hygiene Law 32.21 (fines, suspension, revocation)","url":"https://newyork.public.law/laws/n.y._mental_hygiene_law_section_32.21","primary":true}]},{"id":"new_york_auto_renewal","title":"New York automatic renewal disclosures (GBL 527-a) (NY)","authority":"N.Y. General Business Law art. 29-BB, 527-a (Unlawful practices), in its current comprehensive form enacted as Part W of the New York State FY2026 budget, signed May 9, 2025, effective November 5, 2025. It is unlawful for a business making an automatic renewal or continuous service offer to a New York consumer to fail to present the material terms clearly and conspicuously, including the product, the cost, the frequency of charges, the deadline to cancel, and the cancellation mechanisms, before consent or billing information is requested and in visual proximity to the consent request (527-a(1)(a)); to charge without affirmative consent (527-a(1)(b)); to fail to provide a retainable acknowledgment (527-a(1)(c)); to fail to provide a simple cancellation mechanism that is as easy to use as the mechanism the consumer used to provide consent and through the same medium (527-a(1)(d), (d-1)); to obstruct or unreasonably delay cancellation (527-a(1)(e)); or to omit the free-trial conversion reminder for a free gift or trial of more than a month (527-a(1)(h)). Enforced by the Attorney General.","jurisdiction":"NY","status":"active","reviewed_date":"2026-07-31","review_interval_days":120,"review_method":"mechanical","guard_updated":"2026-07-24","sources":[{"label":"N.Y. Gen. Bus. Law 527-a (automatic renewal, unlawful practices)","url":"https://newyork.public.law/laws/n.y._general_business_law_section_527-a","primary":true},{"label":"N.Y. Gen. Bus. Law 527 (definitions)","url":"https://newyork.public.law/laws/n.y._general_business_law_section_527","primary":true}]},{"id":"new_york_supplement_marketing","title":"New York age restriction on weight-loss and muscle-building supplements (NY GBL 391-oo)","authority":"N.Y. General Business Law 391-oo (Sale of over-the-counter diet pills and dietary supplements for weight loss or muscle building to minors), enacted by Chapter 558 of the Laws of 2023 (S.5823-C / A.5610), effective on or about April 22, 2024 (180 days after signing). It bars selling, offering to sell, or giving away, as a retail or wholesale promotion, an over-the-counter diet pill or a dietary supplement for weight loss or muscle building to any person under eighteen years of age within New York, and requires retail establishments to require proof of legal age (identification need not be required of a person who reasonably appears to be at least twenty-five). Coverage turns on whether the product is labeled, marketed, or otherwise represented for the purpose of achieving weight loss or muscle building. Enforced by the Attorney General; civil penalty up to five hundred dollars per violation. The marketing-based coverage trigger was upheld against a First Amendment challenge (Second Circuit, 2026).","jurisdiction":"NY","status":"active","reviewed_date":"2026-07-24","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-24","sources":[{"label":"N.Y. General Business Law 391-oo (consolidated statute, nysenate.gov)","url":"https://www.nysenate.gov/legislation/laws/GBS/391-OO","primary":true},{"label":"N.Y. S.5823-C (2023), enacting bill text","url":"https://www.nysenate.gov/legislation/bills/2023/S5823/amendment/C","primary":true},{"label":"N.Y. A.5610 (2023), Assembly companion","url":"https://www.nysenate.gov/legislation/bills/2023/A5610","primary":true}]},{"id":"nm_cannabis","title":"New Mexico cannabis advertising and marketing (CCD)","authority":"New Mexico Cannabis Regulation Act, NMSA 1978 Section 26-2C-20 (advertising and marketing restrictions, eff. June 29, 2021); 16.8.3.8 NMAC (Advertising and Marketing, eff. 04/01/2022), Cannabis Control Division, Regulation and Licensing Department.","jurisdiction":"NM","status":"active","reviewed_date":"2026-07-24","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-24","sources":[{"label":"16.8.3 NMAC, Packaging, Labeling, Advertising, Marketing, and Commercial Display Requirements (official NM State Records Center and Archives text)","url":"https://www.srca.nm.gov/parts/title16/16.008.0003.html","primary":true},{"label":"NMSA 1978 Chapter 26 Article 2C, Cannabis Regulation Act (RLD-hosted compilation; Section 26-2C-20 advertising and marketing restrictions)","url":"https://www.rld.nm.gov/wp-content/uploads/2023/08/ARTICLE-2C-Cannabis-Regulation-_-Chapter-26-Drugs-and-Cosmetics.pdf","primary":true}]},{"id":"north_carolina_addiction_marketing","title":"North Carolina addiction treatment patient brokering and deceptive marketing (NC)","authority":"N.C. Gen. Stat. Chapter 90, Article 5H (Substance Use Disorder Facilities and Recovery Residences, the SAFE Act, S.L. 2023-141, effective January 1, 2024). Patient brokering at 90-113.152 (a Class G felony, with each violation a separate offense; exemptions at (b) for a federal Anti-Kickback safe harbor under 42 U.S.C. 1320a-7b(b)(3) and a reasonable contingency-management incentive). Deceptive marketing at 90-113.151 (Truth in Marketing; a Class G felony under (c) and (d), and an unfair or deceptive trade practice under N.C. Gen. Stat. 75-1.1 via (e)). Referral defined at 90-113.150(3). Enforced through North Carolina criminal prosecution, the Attorney General under Chapter 75, and Department of Health and Human Services licensure oversight.","jurisdiction":"NC","status":"active","reviewed_date":"2026-07-30","review_interval_days":150,"review_method":"ai","guard_updated":"2026-07-30","sources":[{"label":"N.C. Gen. Stat. Chapter 90, Article 5H (SAFE Act; 90-113.150 definitions, 90-113.151 Truth in Marketing, 90-113.152 patient brokering)","url":"https://www.ncleg.gov/EnactedLegislation/Statutes/HTML/ByArticle/Chapter_90/Article_5H.html","primary":true}]},{"id":"north_carolina_mental_health_marketing","title":"North Carolina mental health advertising (N.C.G.S. 90-270.148)","authority":"N.C.G.S. 90-270.148(a)(4) (practising fraud, deceit or misrepresentation upon the public in connection with the practice of psychology or the offer of psychological services), and N.C.G.S. 90-340 for licensed clinical mental health counselors.","jurisdiction":"NC","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"N.C.G.S. 90-270.148 (psychology, grounds for discipline)","url":"https://www.ncleg.gov/EnactedLegislation/Statutes/HTML/BySection/Chapter_90/GS_90-270.148.html","primary":true},{"label":"N.C.G.S. 90-340 (licensed clinical mental health counselors, protection of the public)","url":"https://www.ncleg.gov/EnactedLegislation/Statutes/HTML/BySection/Chapter_90/GS_90-340.html","primary":false}]},{"id":"ny_cannabis","title":"New York adult-use cannabis marketing and advertising","authority":"NY Cannabis Law Article 4 Section 86 (advertising and marketing restrictions); 9 NYCRR Part 129 (Adult-Use Marketing and Advertising) with Part 128 definitions, revised regulations adopted per CCB Resolution 2025-81 and filed for State Register publication December 3, 2025; Office of Cannabis Management.","jurisdiction":"NY","status":"active","reviewed_date":"2026-07-31","review_interval_days":120,"review_method":"mechanical","guard_updated":"2026-07-24","sources":[{"label":"9 NYCRR 129.2 (adult-use marketing and advertising, general requirements)","url":"https://www.law.cornell.edu/regulations/new-york/9-NYCRR-129.2","primary":true},{"label":"9 NYCRR 129.3 (adult-use marketing and advertising prohibitions)","url":"https://www.law.cornell.edu/regulations/new-york/9-NYCRR-129.3","primary":true},{"label":"9 NYCRR 128.1 (definitions)","url":"https://www.law.cornell.edu/regulations/new-york/9-NYCRR-128.1","primary":true}]},{"id":"ny_professional_advertising","title":"New York professional advertising (Regents Part 29 and Education Law 6530)","authority":"NY Board of Regents rules on unprofessional conduct, 8 NYCRR 29.1(b)(12), 29.1(b)(2), 29.2 (NYSED Office of the Professions); for physicians, NY Education Law 6530(17), (27), (34), enforced by the Board for Professional Medical Conduct under Public Health Law 230.","jurisdiction":"NY","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-29","sources":[{"label":"NYSED Office of the Professions, Rules of the Board of Regents, Part 29 (Unprofessional Conduct)","url":"https://www.op.nysed.gov/title8/rules-board-regents/part-29","primary":true},{"label":"NY Education Law 6530 (definitions of professional misconduct, physicians), NY Senate official text","url":"https://www.nysenate.gov/legislation/laws/EDN/6530","primary":true},{"label":"NY Public Health Law 230 (Board for Professional Medical Conduct), NY Senate official text","url":"https://www.nysenate.gov/legislation/laws/PBH/230","primary":true}]},{"id":"ohio_addiction_marketing","title":"Ohio addiction treatment marketing (recovery-housing referral advisory; HB 58 watch)","authority":"Ohio R.C. 5119.396 (prohibition against referrals to non-registry recovery housing residences, in force, operative Jan. 1, 2025) and R.C. 5119.394 (OMHAS registry of recovery housing residences). WATCH: Ohio HB 58 (136th General Assembly), which would add a certificate-of-need program for recovery housing and criminalize compensation for patient referrals, passed the House 92-0 on Feb. 25, 2026 and is pending in the Senate; it is not yet law and is not compiled here.","jurisdiction":"OH","status":"active","reviewed_date":"2026-07-23","review_interval_days":90,"review_method":"human","guard_updated":"2026-07-23","sources":[{"label":"Ohio R.C. 5119.396 (prohibition against referrals to non-registry recovery residences)","url":"https://codes.ohio.gov/ohio-revised-code/section-5119.396","primary":true},{"label":"Ohio R.C. 5119.394 (OMHAS registry of recovery housing residences)","url":"https://codes.ohio.gov/ohio-revised-code/section-5119.394","primary":true},{"label":"Ohio HB 58 (136th General Assembly), House-passed 2026-02-25, pending Senate","url":"https://www.legislature.ohio.gov/legislation/136/hb58","primary":true}]},{"id":"ohio_mental_health_marketing","title":"Ohio mental health advertising (OAC 4757-5-02 code of ethics)","authority":"Ohio Admin. Code 4757-5-02 (code of ethical practice for counselors, social workers and marriage and family therapists), which forbids misrepresenting professional qualifications and forbids using identifiable client information or imagery in advertisements or promotional materials without written consent. Ohio Rev. Code 4757.36 carries the discipline.","jurisdiction":"OH","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"Ohio Admin. Code 4757-5-02 (code of ethical practice)","url":"https://codes.ohio.gov/ohio-administrative-code/rule-4757-5-02","primary":true},{"label":"Ohio Rev. Code 4757.36 (counselor and social worker discipline)","url":"https://codes.ohio.gov/ohio-revised-code/section-4757.36","primary":false},{"label":"Ohio Admin. Code 4732-17-01 (psychology rules of conduct)","url":"https://codes.ohio.gov/ohio-administrative-code/rule-4732-17-01","primary":false}]},{"id":"or_cannabis","title":"Oregon OLCC marijuana advertising","authority":"Oregon Liquor and Cannabis Commission: OAR 845-025-8000 to 845-025-8080 (advertising rules; esp. 845-025-8040 Advertising Restrictions), 845-025-8520(9) (marijuana as a prize), 845-025-8540(2)(a)(D) (curative/therapeutic misrepresentation); enabling statute ORS 475C.017(2)(e).","jurisdiction":"OR","status":"active","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"OAR chapter 845 division 25, Recreational Marijuana (current rules, Oregon SOS)","url":"https://secure.sos.state.or.us/oard/displayDivisionRules.action?selectedDivision=3873","primary":true},{"label":"OAR 845-025-8040 Advertising Restrictions (single-rule page, Oregon SOS)","url":"https://secure.sos.state.or.us/oard/viewSingleRule.action?ruleVrsnRsn=239093","primary":true},{"label":"OLCC Cannabis Laws and Rules","url":"https://www.oregon.gov/olcc/marijuana/Pages/Recreational-Marijuana-Laws-and-Rules.aspx","primary":true}]},{"id":"or_psilocybin","title":"Oregon Psilocybin Services advertising (OHA)","authority":"Oregon Health Authority, Oregon Psilocybin Services: OAR 333-333-6100 (Advertising Restrictions), 333-333-6110 (Advertising Media, Coupons, and Promotions), 333-333-6120 (Removal of Objectionable and Non-Conforming Advertising), 333-333-6040(2)(c) (Dishonest Conduct), 333-333-4480(5)(a) (no product discounts or free product); enabling statute ORS 475A.235(2)(e)-(f).","jurisdiction":"OR","status":"active","reviewed_date":"2026-07-29","review_interval_days":120,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"OAR chapter 333 division 333, Oregon Psilocybin Services (current rules, Oregon SOS)","url":"https://secure.sos.state.or.us/oard/displayDivisionRules.action?selectedDivision=7102","primary":true},{"label":"OHA Oregon Psilocybin Services, Administrative Rules and Rulemaking Process","url":"https://www.oregon.gov/oha/ph/preventionwellness/pages/psilocybin-administrative-rules.aspx","primary":true},{"label":"ORS chapter 475A, Psilocybin Regulation (2025 edition, Oregon Legislature)","url":"https://www.oregonlegislature.gov/bills_laws/ors/ors475a.html","primary":true}]},{"id":"oregon_addiction_marketing","title":"Oregon deceptive addiction treatment marketing (OR)","authority":"Oregon Unlawful Trade Practices Act, ORS 646.608 (unlawful trade practices, including false or misleading representations about services), 646.642 (civil penalty up to $25,000 per willful violation), and 646.638 (private action, actual damages or $200). OAR 309-008-0100 et seq. (OHA behavioral health provider certification); residential SUD programs licensed under OAR 415-012. Enforced by the Oregon Attorney General and the Oregon Health Authority.","jurisdiction":"OR","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"ORS 646.608 (unlawful trade practices)","url":"https://oregon.public.law/statutes/ors_646.608","primary":true},{"label":"ORS 646.642 (civil penalties)","url":"https://oregon.public.law/statutes/ors_646.642","primary":true},{"label":"ORS 646.638 (private action)","url":"https://oregon.public.law/statutes/ors_646.638","primary":true}]},{"id":"oregon_professional_advertising","title":"Oregon health professional advertising (ORS 676.612)","authority":"ORS 676.612(2)(b), which makes it prohibited conduct for an authorization holder to use, cause or promote the use of any advertising matter, promotional literature, testimonial, guarantee, warranty, label, insignia or any other representation, however disseminated or published, that is false, misleading or deceptive. The provision is enforced by every health professional regulatory board, and ORS 676.160 enumerates them: the Oregon Board of Dentistry, the Oregon Medical Board, the Oregon Board of Psychology, the Oregon Board of Licensed Professional Counselors and Therapists and the State Board of Licensed Social Workers are all on that list, which is what puts dental, physician-delivered aesthetic, longevity and infusion services, and the talk-therapy professions inside one statute.","jurisdiction":"OR","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"ORS 676.612 (disciplinary authority; prohibited advertising at (2)(b))","url":"https://oregon.public.law/statutes/ors_676.612","primary":true},{"label":"ORS 676.160 (which boards are health professional regulatory boards)","url":"https://oregon.public.law/statutes/ors_676.160","primary":true}]},{"id":"oregon_supplement_advertising","title":"Oregon food and supplement advertising (ORS 616.265)","authority":"ORS 616.265, which deems an advertisement of a food false if it is false or misleading in any particular, read with ORS 616.215, the prohibited-acts section that makes dissemination of a false advertisement unlawful, and ORS 616.275 on liability for that dissemination.","jurisdiction":"OR","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"ORS 616.265 (false advertisement of a food)","url":"https://oregon.public.law/statutes/ors_616.265","primary":true},{"label":"ORS 616.215 (prohibited acts, including dissemination of false advertisement)","url":"https://oregon.public.law/statutes/ors_616.215","primary":true}]},{"id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","authority":"Kesey 50-state substance-use-disorder marketing survey, conducted 2026-07-23. The states listed here were surveyed and found to have no distinctive SUD-specific marketing or patient-brokering statute beyond their general consumer-protection law. The applicable scanned layer for these states is federal: the FTC Act (15 U.S.C. 45) and the Opioid Addiction Recovery Fraud Prevention Act (15 U.S.C. 45d), plus HIPAA and platform rules where they apply. This ruleset adds no rules; it records the survey result and its scope so a scan in these states carries an explicit federal-only note.","jurisdiction":"US","status":"active","reviewed_date":"2026-07-23","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-23","sources":[{"label":"FTC Act Section 5, 15 U.S.C. 45 (unfair or deceptive acts or practices)","url":"https://www.law.cornell.edu/uscode/text/15/45","primary":true},{"label":"Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d","url":"https://www.law.cornell.edu/uscode/text/15/45d","primary":true}]},{"id":"tcpa_calls_and_texts","title":"TCPA consent and revocation in calls and texts (federal, always-on)","authority":"Telephone Consumer Protection Act, 47 U.S.C. 227, as implemented by the FCC at 47 CFR 64.1200. Consent definition at 64.1200(f)(9); revocation at 64.1200(a)(10) (effective April 11, 2025); prerecorded-message identification at 64.1200(b).","jurisdiction":"US","status":"active","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"47 CFR 64.1200, Delivery restrictions (current rule text)","url":"https://www.law.cornell.edu/cfr/text/47/64.1200","primary":true},{"label":"47 U.S.C. 227, Telephone Consumer Protection Act","url":"https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title47-section227&num=0&edition=prelim","primary":true},{"label":"FCC 24-24, Consent revocation Report and Order (February 2024)","url":"https://docs.fcc.gov/public/attachments/FCC-24-24A1.pdf","primary":true}]},{"id":"tennessee_addiction_marketing","title":"Tennessee prohibited addiction treatment marketing practices and provider referral kickbacks (TN)","authority":"Tenn. Code Ann. 33-2-423 (Prohibited Marketing Practices for alcohol and drug treatment: (a)(1) materially false or misleading representations about identity, products, services, or geographic locations; (a)(2) false website information, links, or redirection; (a)(3) soliciting or receiving a kickback or split-fee for a referral; (a)(4) contracting with a marketing provider that generates referrals or leads for patient placement through a call center or web-based presence, subject to a patient-disclosure exception) and Tenn. Code Ann. 63-1-159 (a Title 63 licensed healthcare provider may not knowingly offer, pay, solicit, receive, or aid and abet a commission, benefit, rebate, kickback, bribe, or split-fee to induce a referral to or from a Title 33, chapter 2, part 4 licensee or facility, as to alcohol and drug services under 33-2-402). Both enacted by Public Chapter 855, Acts of 2018 (HB2068), effective July 1 2018. Penalties reach license suspension or revocation under 33-2-407 and civil penalties under 33-2-409, plus license discipline and civil penalties for providers.","jurisdiction":"TN","status":"pending_review","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":null,"sources":[{"label":"Tenn. Code Ann. 33-2-423 (Prohibited Marketing Practices), enacted by Public Chapter 855, Acts of 2018 (HB2068), effective July 1 2018","url":"https://publications.tnsosfiles.com/acts/110/pub/pc0855.pdf","primary":true},{"label":"Tenn. Code Ann. 63-1-159 (provider referral kickback bar), enacted by Public Chapter 855, Acts of 2018 (HB2068), effective July 1 2018","url":"https://publications.tnsosfiles.com/acts/110/pub/pc0855.pdf","primary":true},{"label":"Senate Amendment 1051 to HB2068 (110th General Assembly), the amendment adopted and enacted as Public Chapter 855. Section 1 adds the marketing-practices section to Tenn. Code Ann. Title 33, Chapter 2, Part 4 (codified at 33-2-423) and Section 2 adds the referral kickback bar to Title 63, Chapter 1, Part 1 (codified at 63-1-159). Carries the enacted text; the codified section numbers are assigned by the code reviser and do not appear in it.","url":"https://www.capitol.tn.gov/Bills/110/Amend/SA1051.pdf","primary":true}]},{"id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","authority":"Texas Medical Board, 22 TAC Chapter 164 (esp. 164.3 Misleading or Deceptive Advertising, 164.4, 164.6). Federal: 21 U.S.C. 352, 21 CFR 201.128, 21 CFR 202.1.","jurisdiction":"TX","status":"active","reviewed_date":"2026-07-29","review_interval_days":90,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"22 TAC Chapter 164 (TMB physician advertising, full text)","url":"https://apps.aaem.org/UserFiles/file/texas_medical_board_advertising_rules.pdf","primary":true},{"label":"22 TAC 164.3 (Misleading or Deceptive Advertising)","url":"http://txrules.elaws.us/rule/title22_chapter164_sec.164.3","primary":true},{"label":"21 U.S.C. 352 (misbranding)","url":"https://www.law.cornell.edu/uscode/text/21/352","primary":false}]},{"id":"texas_mental_health_marketing","title":"Texas mental health advertising (22 TAC 681.41)","authority":"22 Tex. Admin. Code 681.41 (Texas State Board of Examiners of Professional Counselors, general ethical requirements), which forbids a licensee from making any false, misleading, deceptive, fraudulent or exaggerated claim about the licensee's services. Tex. Occ. Code 101.201 separately reaches deceptive advertising by health care professionals.","jurisdiction":"TX","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"22 TAC 681.41 (LPC general ethical requirements)","url":"https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-681-41","primary":true},{"label":"Tex. Occ. Code 101.201 (deceptive health care advertising)","url":"https://texas.public.law/statutes/tex._occupations_code_section_101.201","primary":false}]},{"id":"texas_professional_advertising","title":"Texas health professional advertising (Tex. Occ. Code 101.201)","authority":"Tex. Occ. Code 101.201, titled False, Misleading, or Deceptive Advertising, which provides that a person may not use advertising that is false, misleading, deceptive, or not readily subject to verification, and then enumerates nine characteristics that make an advertisement so. It sits in chapter 101, the Health Professions Council, whose member agencies are listed at Tex. Occ. Code 101.002 and include the Texas State Board of Dental Examiners, the Texas Medical Board, the Texas Board of Nursing and the Texas Behavioral Health Executive Council.","jurisdiction":"TX","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"Tex. Occ. Code 101.201 (false, misleading, or deceptive advertising)","url":"https://texas.public.law/statutes/tex._occ._code_section_101.201","primary":true},{"label":"Tex. Occ. Code 101.002 (composition of the Health Professions Council)","url":"https://texas.public.law/statutes/tex._occ._code_section_101.002","primary":true}]},{"id":"texas_supplement_advertising","title":"Texas food and supplement advertising (Tex. H&S Code 431.182)","authority":"Tex. Health & Safety Code 431.182, False Advertisement, in the Texas Food, Drug, and Cosmetic Act. Subsection (a) deems an advertisement of a food false if it is false or misleading in any particular. Subsection (b) is the unusual one and is why Texas is worth its own pack: it deems the advertising of a food that incorporates a health claim NOT IN CONFORMANCE WITH OR DEFINED BY Section 403(r) of the federal Act to be false or misleading, which turns the federal authorized-health-claim list into a Texas advertising standard.","jurisdiction":"TX","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"Tex. Health & Safety Code 431.182(a) (false advertisement of a food)","url":"https://texas.public.law/statutes/tex._health_and_safety_code_section_431.182","primary":true},{"label":"Tex. Health & Safety Code 431.183 (advertising of foods for special dietary use)","url":"https://texas.public.law/statutes/tex._health_and_safety_code_section_431.183","primary":true}]},{"id":"texas_treatment_marketing","title":"Texas Treatment Facilities Marketing Practices Act (TX)","authority":"Tex. Health and Safety Code ch. 164 (Treatment Facilities Marketing Practices Act), covering mental health and chemical dependency facilities. 164.010 marketing prohibitions; 164.005 solicitation compensation limits. Remedies: civil penalties of $1,000 to $25,000 per violation (164.011), private actions under the DTPA (164.013), and license discipline via the licensure cross-penalty (164.012). Enforced by the Texas Attorney General and licensing agencies.","jurisdiction":"TX","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-29","sources":[{"label":"Tex. Health & Safety Code 164.010 (prohibited marketing practices)","url":"https://texas.public.law/statutes/tex._health_and_safety_code_section_164.010","primary":true},{"label":"Tex. Health & Safety Code 164.011 (prohibited referral practices)","url":"https://texas.public.law/statutes/tex._health_and_safety_code_section_164.011","primary":true},{"label":"Tex. Health & Safety Code 164.012 (disciplinary action)","url":"https://texas.public.law/statutes/tex._health_and_safety_code_section_164.012","primary":true}]},{"id":"tx_dental","title":"Texas dental advertising (TSBDE + Dental Practice Act)","authority":"Texas State Board of Dental Examiners, 22 TAC Chapter 108 Subchapter E, Business Promotion (esp. 108.53 Fees, 108.54 Advertising of Specialties, 108.55 Advertising for General Dentists, 108.57 False, Misleading or Deceptive Advertising). Statute: Tex. Occ. Code Ch. 259 (esp. 259.005 Authorized Advertising Restrictions, 259.006 Unlawful Advertising in General).","jurisdiction":"TX","status":"active","reviewed_date":"2026-07-29","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-29","sources":[{"label":"22 TAC Chapter 108 (Texas State Board of Dental Examiners), official Secretary of State TAC viewer","url":"https://texreg.sos.state.tx.us/public/readtac$ext.ViewTAC?tac_view=4&ti=22&pt=5&ch=108","primary":true},{"label":"22 TAC 108.57 (False, Misleading or Deceptive Advertising)","url":"http://txrules.elaws.us/rule/title22_chapter108_sec.108.57","primary":true},{"label":"22 TAC 108.55 (Advertising for General Dentists)","url":"http://txrules.elaws.us/rule/title22_chapter108_sec.108.55","primary":true}]},{"id":"utah_addiction_marketing","title":"Utah deceptive addiction treatment marketing (UT)","authority":"Utah patient-brokering law, Utah Code 26B-2-707 (current citation; recodified from the 2018 enactment at 62A-2-116, through an interim 26B-2-113, enacted by HB 14 and SB 222 in 2018), making it a class A misdemeanor to knowingly and willfully offer, pay, promise, solicit, or receive remuneration (a commission, bonus, kickback, bribe, or rebate), directly or indirectly, overtly or covertly, in cash or in kind, or to engage in a split-fee arrangement, in return for referring an individual for the furnishing or arranging of substance-use-disorder treatment; an information-service safe harbor at 26B-2-707(4)(e) exempts a non-steering service whose fees are set in advance, at fair market value, and not based on the potential value of a patient. Utah Consumer Sales Practices Act, Utah Code 13-11-4 (deceptive act or practice by a supplier; Title 13 was not part of the Title 26B recodification). Enforced through criminal prosecution for patient brokering and, under the Consumer Sales Practices Act, by the Utah Division of Consumer Protection and the Utah Attorney General.","jurisdiction":"UT","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-30","sources":[{"label":"Utah Code 26B-2-707 (operating a program or facility in violation of this chapter, criminal penalties; referral remuneration prohibition at (3), class A misdemeanor; information-service safe harbor at (4)(e)), Title 26B Chapter 2 Part 7 current text","url":"https://le.utah.gov/xcode/Title26B/Chapter2/C26B-2-P7_2024050120240501.pdf","primary":true},{"label":"Utah Code 13-11-4 (Consumer Sales Practices Act, deceptive act or practice by a supplier), Title 13 Chapter 11 current text","url":"https://le.utah.gov/xcode/Title13/Chapter11/C13-11_1800010118000101.pdf","primary":true}]},{"id":"washington_addiction_marketing","title":"Washington conditional bar on advertising opioid or alcohol use disorder treatment (WA)","authority":"RCW 71.24.037(10). Subsection (10)(a) requires a licensed or certified behavioral health agency to give every patient seeking treatment for opioid use disorder or alcohol use disorder, inpatient or outpatient, education on pharmacological treatment options for their diagnosed condition, including an unbiased explanation of all recognized forms of treatment approved by the federal Food and Drug Administration that are clinically appropriate, as required under RCW 7.70.050 and 7.70.060, and to support a patient who elects a clinically appropriate pharmacological option either by directly providing the medication or by a warm handoff referral. Subsection (10)(b) provides that unless it meets (10)(a), a behavioral health agency may not (i) advertise that it treats opioid use disorder or alcohol use disorder, or (ii) treat patients for either condition regardless of the form of treatment the patient chooses. Subsection (10)(c) makes failure an element of proof on informed consent under RCW 7.70.050 and a basis for disciplinary action. Subsection (10)(d) exempts agencies that are units within a hospital licensed under chapter 70.41 RCW or a psychiatric hospital licensed under chapter 71.12 RCW. Amended by 2024 c 366 s 4 and 2024 c 121 s 26.","jurisdiction":"WA","status":"active","reviewed_date":"2026-07-26","review_interval_days":180,"review_method":"human","guard_updated":"2026-07-26","sources":[{"label":"RCW 71.24.037, licensing and certification of behavioral health agencies, subsection (10) (Washington Legislature)","url":"https://app.leg.wa.gov/rcw/default.aspx?cite=71.24.037","primary":true},{"label":"RCW 7.70.050, informed consent, referenced by RCW 71.24.037(10)(a) and (10)(c)","url":"https://app.leg.wa.gov/rcw/default.aspx?cite=7.70.050","primary":true},{"label":"RCW 7.70.060, consent form contents, referenced by RCW 71.24.037(10)(a)","url":"https://app.leg.wa.gov/rcw/default.aspx?cite=7.70.060","primary":true}]},{"id":"washington_mental_health_marketing","title":"Washington mental health advertising (RCW 18.130.180)","authority":"RCW 18.130.180(3) (all advertising which is false, fraudulent, or misleading is unprofessional conduct), part of the Uniform Disciplinary Act, which governs mental health counselors, marriage and family therapists and social workers under RCW 18.225 and psychologists under RCW 18.83.","jurisdiction":"WA","status":"active","reviewed_date":"2026-07-31","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-07-31","sources":[{"label":"RCW 18.130.180 (unprofessional conduct, Uniform Disciplinary Act)","url":"https://app.leg.wa.gov/RCW/default.aspx?cite=18.130.180","primary":true},{"label":"RCW 18.225.090 (counselors and therapists, grounds for discipline)","url":"https://app.leg.wa.gov/RCW/default.aspx?cite=18.225.090","primary":false}]},{"id":"washington_professional_advertising","title":"Washington healing arts advertising (Uniform Disciplinary Act, RCW 18.130.180)","authority":"RCW 18.130.180(3), which makes all advertising which is false, fraudulent, or misleading unprofessional conduct for any license holder under the jurisdiction of chapter 18.130 RCW, the Uniform Disciplinary Act. RCW 18.130.040(2)(b) places the dental quality assurance commission (chapter 18.32 RCW) and the Washington medical commission (chapter 18.71 RCW) under that chapter, so dentists and physicians, including the physicians who deliver aesthetic, longevity and infusion services, are inside it. RCW 18.130.180(7) separately makes violation of any state or federal statute or rule regulating the profession unprofessional conduct, which is the hook that carries federal advertising law into state discipline.","jurisdiction":"WA","status":"active","reviewed_date":"2026-08-04","review_interval_days":180,"review_method":"mechanical","guard_updated":"2026-08-04","sources":[{"label":"RCW 18.130.180 (unprofessional conduct, advertising at subsection (3))","url":"https://app.leg.wa.gov/RCW/default.aspx?cite=18.130.180","primary":true},{"label":"RCW 18.130.040 (which professions the Uniform Disciplinary Act reaches)","url":"https://app.leg.wa.gov/RCW/default.aspx?cite=18.130.040","primary":true}]},{"id":"west_virginia_addiction_marketing","title":"West Virginia Patient Brokering Act, referral payments and recovery residences (WV)","authority":"W. Va. Code chapter 16, article 62 (Patient Brokering Act): 16-62-1 (definitions), 16-62-2 (patient brokering prohibited), 16-62-3 (exceptions). 16-62-2(a) makes it unlawful for any person, including a health care provider, health care facility, or recovery residence, to offer or pay a commission, benefit, bonus, rebate, kickback, or bribe, directly or indirectly, in cash or in kind, to induce the referral of a patient, to solicit or receive such a payment in return for referring a patient, to solicit or receive such a payment in return for accepting a patient for treatment, or to aid, abet, advise, or otherwise participate in that conduct. A violation is punishable by a fine of up to $50,000, imprisonment of one to five years, or both, and where the prohibited conduct involves ten or more patients by a fine of up to $100,000, imprisonment of two to five years, or both (W. Va. Code 16-62-2(b)).","jurisdiction":"WV","status":"active","reviewed_date":"2026-07-30","review_interval_days":180,"review_method":"ai","guard_updated":"2026-07-30","sources":[{"label":"W. Va. Code 16-62-2, patient brokering prohibited (WV Legislature)","url":"https://code.wvlegislature.gov/16-62-2/","primary":true},{"label":"W. Va. Code 16-62-1, definitions (WV Legislature)","url":"https://code.wvlegislature.gov/16-62-1/","primary":true},{"label":"W. Va. Code 16-62-3, exceptions (WV Legislature)","url":"https://code.wvlegislature.gov/16-62-3/","primary":true}]}],"verticals":{"ketamine":"Ketamine clinic","psilocybin":"Psilocybin services","cannabis":"Cannabis","wellness_spa":"Wellness and med spa","dental":"Dental practice","aging":"Aging and longevity clinic","addiction_treatment":"Addiction treatment","mental_health":"Mental health and therapy","dietary_supplements":"Dietary supplements and nutraceuticals","hemp_cbd":"Hemp and CBD"},"asset_types":["email","landing_page","blog","social","video"],"states":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"state_coverage":{"AZ":{"state":"AZ","name":"Arizona","tier":"state","tier_label":"State pack live","ruleset_id":"arizona_addiction_marketing","title":"Arizona addiction treatment patient brokering and sober living home marketing (AZ)","statutes":["A.R.S. 44-1522","A.R.S. 13-3730","A.R.S. 36-2062","A.R.S. 36-2063"],"reviewed_date":"2026-07-30","review_interval_days":90,"detail":"Live state pack. A.R.S. 44-1522; A.R.S. 13-3730; A.R.S. 36-2062. Reviewed 2026-07-30."},"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_addiction_marketing","title":"California deceptive addiction treatment marketing and patient brokering (CA)","statutes":["Cal. HSC 11831.6","Cal. HSC 11831.7","Cal. HSC 11831.9","Cal. Bus. and Prof. Code 17500","Cal. Bus. and Prof. Code 17200","Cal. HSC 11834.01","Cal. HSC 11834.30"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. Cal. HSC 11831.6; Cal. HSC 11831.7; Cal. HSC 11831.9. Reviewed 2026-07-30."},"CO":{"state":"CO","name":"Colorado","tier":"state","tier_label":"State pack live","ruleset_id":"colorado_addiction_marketing","title":"Colorado deceptive addiction treatment marketing (CO)","statutes":["C.R.S. 6-1-105","C.R.S. 6-1-112","C.R.S. 12-245-224(1)(q)","C.R.S. 27-50-501"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. C.R.S. 6-1-105; C.R.S. 6-1-112; C.R.S. 12-245-224(1)(q). Reviewed 2026-07-30."},"DE":{"state":"DE","name":"Delaware","tier":"state","tier_label":"State pack live","ruleset_id":"delaware_addiction_marketing","title":"Delaware deceptive addiction treatment marketing (DE)","statutes":["6 Del. C. Chapter 25F, Patient Brokering","6 Del. C. Chapter 25, Subchapter II, Consumer Fraud"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. 6 Del. C. Chapter 25F, Patient Brokering; 6 Del. C. Chapter 25, Subchapter II, Consumer Fraud. Reviewed 2026-07-30."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"florida_addiction_marketing","title":"Florida deceptive addiction treatment marketing and patient brokering (FL)","statutes":["Fla. Stat. 397.55","Fla. Stat. 817.505","Fla. Stat. 501.605","Fla. Stat. 501.606"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Fla. Stat. 397.55; Fla. Stat. 817.505; Fla. Stat. 501.605. Reviewed 2026-08-04."},"GA":{"state":"GA","name":"Georgia","tier":"state","tier_label":"State pack live","ruleset_id":"georgia_addiction_marketing","title":"Georgia deceptive addiction treatment marketing (GA)","statutes":["O.C.G.A. 26-5-80","O.C.G.A. 10-1-393","Georgia General Assembly SB 4"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. O.C.G.A. 26-5-80; O.C.G.A. 10-1-393; Georgia General Assembly SB 4. Reviewed 2026-07-30."},"KY":{"state":"KY","name":"Kentucky","tier":"state","tier_label":"State pack live","ruleset_id":"kentucky_addiction_marketing","title":"Kentucky prohibition on remuneration for treatment-program referrals (KY)","statutes":["KRS 222.429, prohibition against remuneration for referrals to treatment programs","KRS 222.427, definitions, qualified treatment programs, and the advertising-disclosure rulemaking directive","2024 Ky. Acts ch. 68","908 KAR 1:370, licensing and general requirements for nonhospital-based alcohol and other drug treatment entities","18 U.S.C. 220, Eliminating Kickbacks in Recovery Act, incorporated by KRS 222.429(2) and"],"reviewed_date":"2026-08-11","review_interval_days":180,"detail":"Live state pack. KRS 222.429, prohibition against remuneration for referrals to treatment programs; KRS 222.427, definitions, qualified treatment programs, and the advertising-disclosure rulemaking directive; 2024 Ky. Acts ch. 68. Reviewed 2026-08-11."},"LA":{"state":"LA","name":"Louisiana","tier":"pending","tier_label":"Pending review","ruleset_id":"louisiana_addiction_marketing","title":"Louisiana addiction treatment marketing (LA)","statutes":["La. R.S. 14:70.5.1","La. R.S. 51:1405(A)"],"reviewed_date":"2026-07-29","review_interval_days":90,"detail":"Louisiana has a compiled pack that is not stamped, so scans here surface its findings and citations but fail closed rather than certifying a clean pass. What is outstanding is the review, not the law."},"MN":{"state":"MN","name":"Minnesota","tier":"state","tier_label":"State pack live","ruleset_id":"minnesota_auto_renewal","title":"Minnesota automatic renewal disclosures (Minn. Stat. 325G.57) (MN)","statutes":["Minn. Stat. 325G.57","Minn. Stat. 325G.56","Minn. Stat. 325G.60","Minn. Stat. 325G.58"],"reviewed_date":"2026-07-24","review_interval_days":120,"detail":"Live state pack. Minn. Stat. 325G.57; Minn. Stat. 325G.56; Minn. Stat. 325G.60. Reviewed 2026-07-24."},"NV":{"state":"NV","name":"Nevada","tier":"state","tier_label":"State pack live","ruleset_id":"nevada_addiction_marketing","title":"Nevada prohibited marketing practices for alcohol and drug treatment (NV)","statutes":["NRS 458.112, unlawful acts relating to marketing of treatment","NRS Chapter 458, abuse of alcohol and drugs","18 U.S.C. 220, Eliminating Kickbacks in Recovery Act"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. NRS 458.112, unlawful acts relating to marketing of treatment; NRS Chapter 458, abuse of alcohol and drugs; 18 U.S.C. 220, Eliminating Kickbacks in Recovery Act. Reviewed 2026-07-30."},"NJ":{"state":"NJ","name":"New Jersey","tier":"pending","tier_label":"Pending review","ruleset_id":"new_jersey_addiction_marketing","title":"New Jersey addiction treatment patient brokering and deceptive marketing (NJ)","statutes":["N.J.S.A. 2C:40A-6","N.J.S.A. 56:8-230 to 56:8-232"],"reviewed_date":"2026-07-29","review_interval_days":120,"detail":"New Jersey has a compiled pack that is not stamped, so scans here surface its findings and citations but fail closed rather than certifying a clean pass. What is outstanding is the review, not the law."},"NM":{"state":"NM","name":"New Mexico","tier":"pending","tier_label":"Pending review","ruleset_id":"new_mexico_addiction_marketing","title":"New Mexico deceptive addiction treatment marketing (NM)","statutes":["NMSA 57-12-2","NMSA 57-12-3","NMSA 57-12-10","NMSA 57-12-11"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"New Mexico has a compiled pack that is not stamped, so scans here surface its findings and citations but fail closed rather than certifying a clean pass. What is outstanding is the review, not the law."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"new_york_addiction_marketing","title":"New York deceptive addiction treatment marketing and patient brokering (NY)","statutes":["N.Y. Mental Hygiene Law 32.06","N.Y. Mental Hygiene Law 32.05","N.Y. Mental Hygiene Law 32.21","N.Y. General Business Law 349","N.Y. General Business Law 350","N.Y. General Business Law 350-a"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. N.Y. Mental Hygiene Law 32.06; N.Y. Mental Hygiene Law 32.05; N.Y. Mental Hygiene Law 32.21. Reviewed 2026-07-30."},"NC":{"state":"NC","name":"North Carolina","tier":"state","tier_label":"State pack live","ruleset_id":"north_carolina_addiction_marketing","title":"North Carolina addiction treatment patient brokering and deceptive marketing (NC)","statutes":["N.C. Gen. Stat. Chapter 90, Article 5H"],"reviewed_date":"2026-07-30","review_interval_days":150,"detail":"Live state pack. N.C. Gen. Stat. Chapter 90, Article 5H. Reviewed 2026-07-30."},"OH":{"state":"OH","name":"Ohio","tier":"watch","tier_label":"Watch","ruleset_id":"ohio_addiction_marketing","title":"Ohio addiction treatment marketing (recovery-housing referral advisory; HB 58 watch)","statutes":[],"reviewed_date":"2026-07-23","review_interval_days":90,"detail":"Watch. An enacted obligation is surfaced as a standing notice; pending legislation is documented but not compiled. Reviewed 2026-07-23."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"oregon_addiction_marketing","title":"Oregon deceptive addiction treatment marketing (OR)","statutes":["ORS 646.608","ORS 646.642","ORS 646.638","OAR 309-008-0100"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. ORS 646.608; ORS 646.642; ORS 646.638. Reviewed 2026-07-30."},"AL":{"state":"AL","name":"Alabama","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"AK":{"state":"AK","name":"Alaska","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"AR":{"state":"AR","name":"Arkansas","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"CT":{"state":"CT","name":"Connecticut","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"DC":{"state":"DC","name":"District of Columbia","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"HI":{"state":"HI","name":"Hawaii","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"ID":{"state":"ID","name":"Idaho","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"IL":{"state":"IL","name":"Illinois","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"IN":{"state":"IN","name":"Indiana","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"IA":{"state":"IA","name":"Iowa","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"KS":{"state":"KS","name":"Kansas","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"ME":{"state":"ME","name":"Maine","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MD":{"state":"MD","name":"Maryland","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MA":{"state":"MA","name":"Massachusetts","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MI":{"state":"MI","name":"Michigan","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MS":{"state":"MS","name":"Mississippi","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MO":{"state":"MO","name":"Missouri","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"MT":{"state":"MT","name":"Montana","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"NE":{"state":"NE","name":"Nebraska","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"NH":{"state":"NH","name":"New Hampshire","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"ND":{"state":"ND","name":"North Dakota","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"OK":{"state":"OK","name":"Oklahoma","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"PA":{"state":"PA","name":"Pennsylvania","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"RI":{"state":"RI","name":"Rhode Island","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"SC":{"state":"SC","name":"South Carolina","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"SD":{"state":"SD","name":"South Dakota","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"VT":{"state":"VT","name":"Vermont","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"VA":{"state":"VA","name":"Virginia","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"WI":{"state":"WI","name":"Wisconsin","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"WY":{"state":"WY","name":"Wyoming","tier":"federal_only","tier_label":"Federal layer only","ruleset_id":"state_survey_federal_only","title":"State SUD-marketing survey: federal-only jurisdictions (no distinctive state law)","statutes":["FTC Act Section 5, 15 U.S.C. 45","Opioid Addiction Recovery Fraud Prevention Act of 2018, 15 U.S.C. 45d"],"reviewed_date":"2026-07-23","review_interval_days":180,"detail":"No distinctive state SUD-marketing statute as of the 2026-07-23 survey. The federal layer is scanned; general state consumer-protection law applies and is not scanned."},"TN":{"state":"TN","name":"Tennessee","tier":"pending","tier_label":"Pending review","ruleset_id":"tennessee_addiction_marketing","title":"Tennessee prohibited addiction treatment marketing practices and provider referral kickbacks (TN)","statutes":["Tenn. Code Ann. 33-2-423","Tenn. Code Ann. 63-1-159","Senate Amendment 1051 to HB2068"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Tennessee has a compiled pack that is not stamped, so scans here surface its findings and citations but fail closed rather than certifying a clean pass. What is outstanding is the review, not the law."},"TX":{"state":"TX","name":"Texas","tier":"state","tier_label":"State pack live","ruleset_id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","statutes":["22 TAC Chapter 164","22 TAC 164.3","Meta Advertising Standards, Drugs and Pharmaceuticals","TMB Rule Changes"],"reviewed_date":"2026-07-29","review_interval_days":90,"detail":"Live state pack. 22 TAC Chapter 164; 22 TAC 164.3; Meta Advertising Standards, Drugs and Pharmaceuticals. Reviewed 2026-07-29."},"UT":{"state":"UT","name":"Utah","tier":"state","tier_label":"State pack live","ruleset_id":"utah_addiction_marketing","title":"Utah deceptive addiction treatment marketing (UT)","statutes":["Utah Code 26B-2-707","Utah Code 13-11-4"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. Utah Code 26B-2-707; Utah Code 13-11-4. Reviewed 2026-07-30."},"WA":{"state":"WA","name":"Washington","tier":"advisory","tier_label":"State law, advisory","ruleset_id":"washington_addiction_marketing","title":"Washington conditional bar on advertising opioid or alcohol use disorder treatment (WA)","statutes":["RCW 71.24.037, licensing and certification of behavioral health agencies, subsection","RCW 7.70.050, informed consent, referenced by RCW 71.24.037(10)(a) and","RCW 7.70.060, consent form contents, referenced by RCW 71.24.037(10)(a)"],"reviewed_date":"2026-07-26","review_interval_days":180,"detail":"Adopted Washington law in force, carried as a standing advisory rather than pattern rules because the obligation turns on a fact about the advertiser that copy cannot show. Every scan here raises it. Reviewed 2026-07-26."},"WV":{"state":"WV","name":"West Virginia","tier":"state","tier_label":"State pack live","ruleset_id":"west_virginia_addiction_marketing","title":"West Virginia Patient Brokering Act, referral payments and recovery residences (WV)","statutes":["W. Va. Code 16-62-2, patient brokering prohibited","W. Va. Code 16-62-1, definitions","W. Va. Code 16-62-3, exceptions","W. Va. Code chapter 16, article 62, Patient Brokering Act"],"reviewed_date":"2026-07-30","review_interval_days":180,"detail":"Live state pack. W. Va. Code 16-62-2, patient brokering prohibited; W. Va. Code 16-62-1, definitions; W. Va. Code 16-62-3, exceptions. Reviewed 2026-07-30."}},"coverage_by_vertical":{"ketamine":{"tiers":{"CA":"state","FL":"state","MN":"not_surveyed","NY":"state","OR":"state","TX":"state","WA":"state","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CO":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NM":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_professional_advertising","title":"California healing arts advertising (BPC 651)","statutes":["Cal. Bus. & Prof. Code 651","Cal. Bus. & Prof. Code 651, official California Legislative Information"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Cal. Bus. & Prof. Code 651; Cal. Bus. & Prof. Code 651, official California Legislative Information. Reviewed 2026-08-04."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"florida_ketamine","title":"Florida Board of Medicine advertising (physician-supervised care)","statutes":["Rule 64B8-11.001 F.A.C.","Rule 64B15-14.001 F.A.C.","Fla. Stat. 458.331","Fla. Stat. 456.062"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. Rule 64B8-11.001 F.A.C.; Rule 64B15-14.001 F.A.C.; Fla. Stat. 458.331. Reviewed 2026-07-29."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"ny_professional_advertising","title":"New York professional advertising (Regents Part 29 and Education Law 6530)","statutes":["NYSED Office of the Professions, Rules of the Board of Regents, Part 29","NY Education Law 6530","NY Public Health Law 230"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. NYSED Office of the Professions, Rules of the Board of Regents, Part 29; NY Education Law 6530; NY Public Health Law 230. Reviewed 2026-07-31."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"oregon_professional_advertising","title":"Oregon health professional advertising (ORS 676.612)","statutes":["ORS 676.612","ORS 676.160"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. ORS 676.612; ORS 676.160. Reviewed 2026-08-04."},"TX":{"state":"TX","name":"Texas","tier":"state","tier_label":"State pack live","ruleset_id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","statutes":["22 TAC Chapter 164","22 TAC 164.3","Meta Advertising Standards, Drugs and Pharmaceuticals","TMB Rule Changes"],"reviewed_date":"2026-07-29","review_interval_days":90,"detail":"Live state pack. 22 TAC Chapter 164; 22 TAC 164.3; Meta Advertising Standards, Drugs and Pharmaceuticals. Reviewed 2026-07-29."},"WA":{"state":"WA","name":"Washington","tier":"state","tier_label":"State pack live","ruleset_id":"washington_professional_advertising","title":"Washington healing arts advertising (Uniform Disciplinary Act, RCW 18.130.180)","statutes":["RCW 18.130.180","RCW 18.130.040"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. RCW 18.130.180; RCW 18.130.040. Reviewed 2026-08-04."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Ketamine clinic advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"psilocybin":{"tiers":{"CA":"not_surveyed","CO":"state","MN":"not_surveyed","NM":"not_yet_regulated","NY":"not_surveyed","OR":"state","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","FL":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","TX":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CO":{"state":"CO","name":"Colorado","tier":"state","tier_label":"State pack live","ruleset_id":"co_nmha_dora","title":"Colorado Natural Medicine advertising (NMHA / DNM)","statutes":["1 CCR 213-1","4 CCR 755-1 Sec. 7 Advertising","C.R.S. 12-170-105","C.R.S. 44-50-203"],"reviewed_date":"2026-07-29","review_interval_days":120,"detail":"Live state pack. 1 CCR 213-1; 4 CCR 755-1 Sec. 7 Advertising; C.R.S. 12-170-105. Reviewed 2026-07-29."},"NM":{"state":"NM","name":"New Mexico","tier":"not_yet_regulated","tier_label":"No adopted rules yet","ruleset_id":"new_mexico_psilocybin","title":"New Mexico medical psilocybin (no adopted advertising rules)","statutes":["New Mexico SB 219, Medical Psilocybin Act","NM DOH Medical Psilocybin Program","NM DOH Rules and Regulations"],"reviewed_date":null,"review_interval_days":null,"detail":"New Mexico has adopted no advertising rules for this vertical to compile (no adopted advertising rules as of 2026-07-18). A scan runs the federal layer and fails closed here rather than certifying a clean pass on a jurisdiction with nothing to certify against."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"or_psilocybin","title":"Oregon Psilocybin Services advertising (OHA)","statutes":["OAR chapter 333 division 333, Oregon Psilocybin Services","OHA Oregon Psilocybin Services, Administrative Rules and Rulemaking Process","ORS chapter 475A, Psilocybin Regulation","Google Ads Dangerous products or services policy","Meta Advertising Standards, Drugs and Pharmaceuticals"],"reviewed_date":"2026-07-29","review_interval_days":120,"detail":"Live state pack. OAR chapter 333 division 333, Oregon Psilocybin Services; OHA Oregon Psilocybin Services, Administrative Rules and Rulemaking Process; ORS chapter 475A, Psilocybin Regulation. Reviewed 2026-07-29."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Psilocybin services advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"cannabis":{"tiers":{"CA":"not_surveyed","CO":"state","FL":"state","MN":"not_surveyed","NY":"state","NM":"state","OR":"state","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","TX":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CO":{"state":"CO","name":"Colorado","tier":"state","tier_label":"State pack live","ruleset_id":"co_cannabis","title":"Colorado regulated marijuana signage and advertising (MED)","statutes":["1 CCR 212-3 Colorado Marijuana Rules","1 CCR 212-3 Rule 3-705 Advertising General Requirements"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. 1 CCR 212-3 Colorado Marijuana Rules; 1 CCR 212-3 Rule 3-705 Advertising General Requirements. Reviewed 2026-07-29."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"fl_medical_marijuana","title":"Florida MMTC advertising and marketing (DOH approval regime)","statutes":["Fla. Stat. 381.986","Florida DOH Emergency Rule 64ER25-6, MMTC Advertising and Marketing","64ER25-6 full rule text","Office of Medical Marijuana Use, rules and regulations page"],"reviewed_date":"2026-07-28","review_interval_days":180,"detail":"Live state pack. Fla. Stat. 381.986; Florida DOH Emergency Rule 64ER25-6, MMTC Advertising and Marketing; 64ER25-6 full rule text. Reviewed 2026-07-28."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"ny_cannabis","title":"New York adult-use cannabis marketing and advertising","statutes":["9 NYCRR 129.2","9 NYCRR 129.3","9 NYCRR 128.1","N.Y. Cannabis Law 86"],"reviewed_date":"2026-07-31","review_interval_days":120,"detail":"Live state pack. 9 NYCRR 129.2; 9 NYCRR 129.3; 9 NYCRR 128.1. Reviewed 2026-07-31."},"NM":{"state":"NM","name":"New Mexico","tier":"state","tier_label":"State pack live","ruleset_id":"nm_cannabis","title":"New Mexico cannabis advertising and marketing (CCD)","statutes":["16.8.3 NMAC, Packaging, Labeling, Advertising, Marketing, and Commercial Display Requirements","NMSA 1978 Chapter 26 Article 2C, Cannabis Regulation Act"],"reviewed_date":"2026-07-24","review_interval_days":180,"detail":"Live state pack. 16.8.3 NMAC, Packaging, Labeling, Advertising, Marketing, and Commercial Display Requirements; NMSA 1978 Chapter 26 Article 2C, Cannabis Regulation Act. Reviewed 2026-07-24."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"or_cannabis","title":"Oregon OLCC marijuana advertising","statutes":["OAR chapter 845 division 25, Recreational Marijuana","OAR 845-025-8040 Advertising Restrictions","OLCC Cannabis Laws and Rules","ORS chapter 475C, Cannabis Regulation","Google Ads Dangerous products or services policy","Meta Advertising Standards, Drugs and Pharmaceuticals"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. OAR chapter 845 division 25, Recreational Marijuana; OAR 845-025-8040 Advertising Restrictions; OLCC Cannabis Laws and Rules. Reviewed 2026-07-29."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Cannabis advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"wellness_spa":{"tiers":{"CA":"state","FL":"state","MN":"not_surveyed","NY":"state","OR":"state","TX":"state","WA":"state","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CO":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NM":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_professional_advertising","title":"California healing arts advertising (BPC 651)","statutes":["Cal. Bus. & Prof. Code 651","Cal. Bus. & Prof. Code 651, official California Legislative Information"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Cal. Bus. & Prof. Code 651; Cal. Bus. & Prof. Code 651, official California Legislative Information. Reviewed 2026-08-04."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"florida_ketamine","title":"Florida Board of Medicine advertising (physician-supervised care)","statutes":["Rule 64B8-11.001 F.A.C.","Rule 64B15-14.001 F.A.C.","Fla. Stat. 458.331","Fla. Stat. 456.062"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. Rule 64B8-11.001 F.A.C.; Rule 64B15-14.001 F.A.C.; Fla. Stat. 458.331. Reviewed 2026-07-29."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"ny_professional_advertising","title":"New York professional advertising (Regents Part 29 and Education Law 6530)","statutes":["NYSED Office of the Professions, Rules of the Board of Regents, Part 29","NY Education Law 6530","NY Public Health Law 230"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. NYSED Office of the Professions, Rules of the Board of Regents, Part 29; NY Education Law 6530; NY Public Health Law 230. Reviewed 2026-07-31."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"oregon_professional_advertising","title":"Oregon health professional advertising (ORS 676.612)","statutes":["ORS 676.612","ORS 676.160"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. ORS 676.612; ORS 676.160. Reviewed 2026-08-04."},"TX":{"state":"TX","name":"Texas","tier":"state","tier_label":"State pack live","ruleset_id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","statutes":["22 TAC Chapter 164","22 TAC 164.3","Meta Advertising Standards, Drugs and Pharmaceuticals","TMB Rule Changes"],"reviewed_date":"2026-07-29","review_interval_days":90,"detail":"Live state pack. 22 TAC Chapter 164; 22 TAC 164.3; Meta Advertising Standards, Drugs and Pharmaceuticals. Reviewed 2026-07-29."},"WA":{"state":"WA","name":"Washington","tier":"state","tier_label":"State pack live","ruleset_id":"washington_professional_advertising","title":"Washington healing arts advertising (Uniform Disciplinary Act, RCW 18.130.180)","statutes":["RCW 18.130.180","RCW 18.130.040"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. RCW 18.130.180; RCW 18.130.040. Reviewed 2026-08-04."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Wellness and med spa advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"dental":{"tiers":{"CA":"state","FL":"state","MN":"not_surveyed","NY":"state","OR":"state","TX":"state","WA":"state","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CO":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NM":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_professional_advertising","title":"California healing arts advertising (BPC 651)","statutes":["Cal. Bus. & Prof. Code 651","Cal. Bus. & Prof. Code 651, official California Legislative Information"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Cal. Bus. & Prof. Code 651; Cal. Bus. & Prof. Code 651, official California Legislative Information. Reviewed 2026-08-04."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"fl_dental","title":"Florida dental advertising (Board of Dentistry)","statutes":["Fla. Stat. 466.019","Fla. Stat. 466.0282","Fla. Stat. 466.028","Fla. Stat. 456.062","Rule 64B5-4.002 F.A.C.","Rule 64B5-4.002 amendment notice","Chapter 64B5-4 F.A.C. rule listing"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. Fla. Stat. 466.019; Fla. Stat. 466.0282; Fla. Stat. 466.028. Reviewed 2026-07-29."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"ny_professional_advertising","title":"New York professional advertising (Regents Part 29 and Education Law 6530)","statutes":["NYSED Office of the Professions, Rules of the Board of Regents, Part 29","NY Education Law 6530","NY Public Health Law 230"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. NYSED Office of the Professions, Rules of the Board of Regents, Part 29; NY Education Law 6530; NY Public Health Law 230. Reviewed 2026-07-31."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"oregon_professional_advertising","title":"Oregon health professional advertising (ORS 676.612)","statutes":["ORS 676.612","ORS 676.160"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. ORS 676.612; ORS 676.160. Reviewed 2026-08-04."},"TX":{"state":"TX","name":"Texas","tier":"state","tier_label":"State pack live","ruleset_id":"tx_dental","title":"Texas dental advertising (TSBDE + Dental Practice Act)","statutes":["22 TAC Chapter 108","22 TAC 108.57","22 TAC 108.55","22 TAC 108.54","22 TAC 108.53","22 TAC Chapter 108 table of contents","Tex. Occ. Code Chapter 259, official text"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. 22 TAC Chapter 108; 22 TAC 108.57; 22 TAC 108.55. Reviewed 2026-07-29."},"WA":{"state":"WA","name":"Washington","tier":"state","tier_label":"State pack live","ruleset_id":"washington_professional_advertising","title":"Washington healing arts advertising (Uniform Disciplinary Act, RCW 18.130.180)","statutes":["RCW 18.130.180","RCW 18.130.040"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. RCW 18.130.180; RCW 18.130.040. Reviewed 2026-08-04."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Dental practice advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"aging":{"tiers":{"CA":"state","FL":"state","MN":"not_surveyed","NY":"state","OR":"state","TX":"state","WA":"state","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CO":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NM":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_professional_advertising","title":"California healing arts advertising (BPC 651)","statutes":["Cal. Bus. & Prof. Code 651","Cal. Bus. & Prof. Code 651, official California Legislative Information"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Cal. Bus. & Prof. Code 651; Cal. Bus. & Prof. Code 651, official California Legislative Information. Reviewed 2026-08-04."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"florida_ketamine","title":"Florida Board of Medicine advertising (physician-supervised care)","statutes":["Rule 64B8-11.001 F.A.C.","Rule 64B15-14.001 F.A.C.","Fla. Stat. 458.331","Fla. Stat. 456.062"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. Rule 64B8-11.001 F.A.C.; Rule 64B15-14.001 F.A.C.; Fla. Stat. 458.331. Reviewed 2026-07-29."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"ny_professional_advertising","title":"New York professional advertising (Regents Part 29 and Education Law 6530)","statutes":["NYSED Office of the Professions, Rules of the Board of Regents, Part 29","NY Education Law 6530","NY Public Health Law 230"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. NYSED Office of the Professions, Rules of the Board of Regents, Part 29; NY Education Law 6530; NY Public Health Law 230. Reviewed 2026-07-31."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"oregon_professional_advertising","title":"Oregon health professional advertising (ORS 676.612)","statutes":["ORS 676.612","ORS 676.160"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. ORS 676.612; ORS 676.160. Reviewed 2026-08-04."},"TX":{"state":"TX","name":"Texas","tier":"state","tier_label":"State pack live","ruleset_id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","statutes":["22 TAC Chapter 164","22 TAC 164.3","Meta Advertising Standards, Drugs and Pharmaceuticals","TMB Rule Changes"],"reviewed_date":"2026-07-29","review_interval_days":90,"detail":"Live state pack. 22 TAC Chapter 164; 22 TAC 164.3; Meta Advertising Standards, Drugs and Pharmaceuticals. Reviewed 2026-07-29."},"WA":{"state":"WA","name":"Washington","tier":"state","tier_label":"State pack live","ruleset_id":"washington_professional_advertising","title":"Washington healing arts advertising (Uniform Disciplinary Act, RCW 18.130.180)","statutes":["RCW 18.130.180","RCW 18.130.040"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. RCW 18.130.180; RCW 18.130.040. Reviewed 2026-08-04."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Aging and longevity clinic advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"addiction_treatment":{"tiers":{"AZ":"state","CA":"state","CO":"state","DE":"state","FL":"state","GA":"state","KY":"state","LA":"pending","MN":"state","NV":"state","NJ":"pending","NM":"pending","NY":"state","NC":"state","OH":"watch","OR":"state","AL":"federal_only","AK":"federal_only","AR":"federal_only","CT":"federal_only","DC":"federal_only","HI":"federal_only","ID":"federal_only","IL":"federal_only","IN":"federal_only","IA":"federal_only","KS":"federal_only","ME":"federal_only","MD":"federal_only","MA":"federal_only","MI":"federal_only","MS":"federal_only","MO":"federal_only","MT":"federal_only","NE":"federal_only","NH":"federal_only","ND":"federal_only","OK":"federal_only","PA":"federal_only","RI":"federal_only","SC":"federal_only","SD":"federal_only","VT":"federal_only","VA":"federal_only","WI":"federal_only","WY":"federal_only","TN":"pending","TX":"state","UT":"state","WA":"advisory","WV":"state"},"entries":{},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Addiction treatment advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"mental_health":{"tiers":{"AZ":"state","CA":"state","CO":"state","FL":"state","MN":"state","NY":"state","NC":"state","OH":"state","OR":"state","TX":"state","WA":"state","AL":"not_surveyed","AK":"not_surveyed","AR":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NM":"not_surveyed","ND":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"AZ":{"state":"AZ","name":"Arizona","tier":"state","tier_label":"State pack live","ruleset_id":"arizona_mental_health_marketing","title":"Arizona mental health advertising (A.R.S. 32-3251)","statutes":["A.R.S. 32-3251"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. A.R.S. 32-3251. Reviewed 2026-07-31."},"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_mental_health_marketing","title":"California mental health advertising (BPC 651 healing arts)","statutes":["Cal. Bus. & Prof. Code 651","Cal. Bus. & Prof. Code 651"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. Cal. Bus. & Prof. Code 651; Cal. Bus. & Prof. Code 651. Reviewed 2026-07-31."},"CO":{"state":"CO","name":"Colorado","tier":"state","tier_label":"State pack live","ruleset_id":"colorado_mental_health_marketing","title":"Colorado mental health advertising (C.R.S. 12-245-224)","statutes":["C.R.S. 12-245-224"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. C.R.S. 12-245-224. Reviewed 2026-07-31."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"florida_ketamine","title":"Florida Board of Medicine advertising (physician-supervised care)","statutes":["Rule 64B8-11.001 F.A.C.","Rule 64B15-14.001 F.A.C.","Fla. Stat. 458.331","Fla. Stat. 456.062"],"reviewed_date":"2026-07-29","review_interval_days":180,"detail":"Live state pack. Rule 64B8-11.001 F.A.C.; Rule 64B15-14.001 F.A.C.; Fla. Stat. 458.331. Reviewed 2026-07-29."},"MN":{"state":"MN","name":"Minnesota","tier":"state","tier_label":"State pack live","ruleset_id":"minnesota_mental_health_marketing","title":"Minnesota mental health advertising (Minn. Stat. 148.98 code of conduct)","statutes":["Minn. Stat. 148.98"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. Minn. Stat. 148.98. Reviewed 2026-07-31."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"ny_professional_advertising","title":"New York professional advertising (Regents Part 29 and Education Law 6530)","statutes":["NYSED Office of the Professions, Rules of the Board of Regents, Part 29","NY Education Law 6530","NY Public Health Law 230"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. NYSED Office of the Professions, Rules of the Board of Regents, Part 29; NY Education Law 6530; NY Public Health Law 230. Reviewed 2026-07-31."},"NC":{"state":"NC","name":"North Carolina","tier":"state","tier_label":"State pack live","ruleset_id":"north_carolina_mental_health_marketing","title":"North Carolina mental health advertising (N.C.G.S. 90-270.148)","statutes":["N.C.G.S. 90-270.148"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. N.C.G.S. 90-270.148. Reviewed 2026-07-31."},"OH":{"state":"OH","name":"Ohio","tier":"state","tier_label":"State pack live","ruleset_id":"ohio_mental_health_marketing","title":"Ohio mental health advertising (OAC 4757-5-02 code of ethics)","statutes":["Ohio Admin. Code 4757-5-02"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. Ohio Admin. Code 4757-5-02. Reviewed 2026-07-31."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"oregon_professional_advertising","title":"Oregon health professional advertising (ORS 676.612)","statutes":["ORS 676.612","ORS 676.160"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. ORS 676.612; ORS 676.160. Reviewed 2026-08-04."},"TX":{"state":"TX","name":"Texas","tier":"state","tier_label":"State pack live","ruleset_id":"texas_ketamine","title":"Texas Medical Board advertising and FDA off-label drug marketing (physician-supervised care)","statutes":["22 TAC Chapter 164","22 TAC 164.3","Meta Advertising Standards, Drugs and Pharmaceuticals","TMB Rule Changes"],"reviewed_date":"2026-07-29","review_interval_days":90,"detail":"Live state pack. 22 TAC Chapter 164; 22 TAC 164.3; Meta Advertising Standards, Drugs and Pharmaceuticals. Reviewed 2026-07-29."},"WA":{"state":"WA","name":"Washington","tier":"state","tier_label":"State pack live","ruleset_id":"washington_mental_health_marketing","title":"Washington mental health advertising (RCW 18.130.180)","statutes":["RCW 18.130.180"],"reviewed_date":"2026-07-31","review_interval_days":180,"detail":"Live state pack. RCW 18.130.180. Reviewed 2026-07-31."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Mental health and therapy advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"dietary_supplements":{"tiers":{"CA":"state","CO":"state","FL":"state","MN":"not_surveyed","NY":"state","OR":"state","TX":"state","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NM":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_prop65_listings","title":"California Proposition 65 e-commerce listing-page warnings for supplements, hemp/CBD, med spa, and longevity products (CA)","statutes":["Cal. Health and Safety Code 25249.6","OEHHA, Proposition 65 clear and reasonable warnings, safe-harbor methods and content","OEHHA short-form warning amendment","OEHHA P65Warnings, safe-harbor warning content and methods"],"reviewed_date":"2026-07-24","review_interval_days":180,"detail":"Live state pack. Cal. Health and Safety Code 25249.6; OEHHA, Proposition 65 clear and reasonable warnings, safe-harbor methods and content; OEHHA short-form warning amendment. Reviewed 2026-07-24."},"CO":{"state":"CO","name":"Colorado","tier":"state","tier_label":"State pack live","ruleset_id":"colorado_supplement_advertising","title":"Colorado food and supplement advertising (C.R.S. 25-5-418)","statutes":["C.R.S. 25-5-418(1)","C.R.S. 25-5-402"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. C.R.S. 25-5-418(1); C.R.S. 25-5-402. Reviewed 2026-08-04."},"FL":{"state":"FL","name":"Florida","tier":"state","tier_label":"State pack live","ruleset_id":"florida_supplement_advertising","title":"Florida food and supplement advertising (Fla. Stat. 500.04)","statutes":["Fla. Stat. 500.04(5)","Fla. Stat. 500.11"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Fla. Stat. 500.04(5); Fla. Stat. 500.11. Reviewed 2026-08-04."},"NY":{"state":"NY","name":"New York","tier":"state","tier_label":"State pack live","ruleset_id":"new_york_supplement_marketing","title":"New York age restriction on weight-loss and muscle-building supplements (NY GBL 391-oo)","statutes":["N.Y. General Business Law 391-oo","N.Y. S.5823-C","N.Y. A.5610"],"reviewed_date":"2026-07-24","review_interval_days":180,"detail":"Live state pack. N.Y. General Business Law 391-oo; N.Y. S.5823-C; N.Y. A.5610. Reviewed 2026-07-24."},"OR":{"state":"OR","name":"Oregon","tier":"state","tier_label":"State pack live","ruleset_id":"oregon_supplement_advertising","title":"Oregon food and supplement advertising (ORS 616.265)","statutes":["ORS 616.265","ORS 616.215"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. ORS 616.265; ORS 616.215. Reviewed 2026-08-04."},"TX":{"state":"TX","name":"Texas","tier":"state","tier_label":"State pack live","ruleset_id":"texas_supplement_advertising","title":"Texas food and supplement advertising (Tex. H&S Code 431.182)","statutes":["Tex. Health & Safety Code 431.182(a)","Tex. Health & Safety Code 431.183"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Tex. Health & Safety Code 431.182(a); Tex. Health & Safety Code 431.183. Reviewed 2026-08-04."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Dietary supplements and nutraceuticals advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."},"hemp_cbd":{"tiers":{"CA":"state","MN":"state","NY":"not_surveyed","AL":"not_surveyed","AK":"not_surveyed","AZ":"not_surveyed","AR":"not_surveyed","CO":"not_surveyed","CT":"not_surveyed","DE":"not_surveyed","DC":"not_surveyed","FL":"not_surveyed","GA":"not_surveyed","HI":"not_surveyed","ID":"not_surveyed","IL":"not_surveyed","IN":"not_surveyed","IA":"not_surveyed","KS":"not_surveyed","KY":"not_surveyed","LA":"not_surveyed","ME":"not_surveyed","MD":"not_surveyed","MA":"not_surveyed","MI":"not_surveyed","MS":"not_surveyed","MO":"not_surveyed","MT":"not_surveyed","NE":"not_surveyed","NV":"not_surveyed","NH":"not_surveyed","NJ":"not_surveyed","NM":"not_surveyed","NC":"not_surveyed","ND":"not_surveyed","OH":"not_surveyed","OK":"not_surveyed","OR":"not_surveyed","PA":"not_surveyed","RI":"not_surveyed","SC":"not_surveyed","SD":"not_surveyed","TN":"not_surveyed","TX":"not_surveyed","UT":"not_surveyed","VT":"not_surveyed","VA":"not_surveyed","WA":"not_surveyed","WV":"not_surveyed","WI":"not_surveyed","WY":"not_surveyed"},"entries":{"CA":{"state":"CA","name":"California","tier":"state","tier_label":"State pack live","ruleset_id":"california_prop65_listings","title":"California Proposition 65 e-commerce listing-page warnings for supplements, hemp/CBD, med spa, and longevity products (CA)","statutes":["Cal. Health and Safety Code 25249.6","OEHHA, Proposition 65 clear and reasonable warnings, safe-harbor methods and content","OEHHA short-form warning amendment","OEHHA P65Warnings, safe-harbor warning content and methods"],"reviewed_date":"2026-07-24","review_interval_days":180,"detail":"Live state pack. Cal. Health and Safety Code 25249.6; OEHHA, Proposition 65 clear and reasonable warnings, safe-harbor methods and content; OEHHA short-form warning amendment. Reviewed 2026-07-24."},"MN":{"state":"MN","name":"Minnesota","tier":"state","tier_label":"State pack live","ruleset_id":"minnesota_hemp_advertising","title":"Minnesota hemp and cannabis advertising (Minn. Stat. 342.64)","statutes":["Minn. Stat. 342.64","Minn. Stat. 342.63"],"reviewed_date":"2026-08-04","review_interval_days":180,"detail":"Live state pack. Minn. Stat. 342.64; Minn. Stat. 342.63. Reviewed 2026-08-04."}},"not_surveyed_detail":"The federal layer and any platform rules are scanned here. {state} has not been surveyed for Hemp and CBD advertising law, so this is not a finding that no such law exists. General state consumer-protection law applies and is not scanned."}},"coverage_legend":[{"tier":"state","label":"State pack live"},{"tier":"advisory","label":"State law, advisory"},{"tier":"watch","label":"Watch"},{"tier":"not_yet_regulated","label":"No adopted rules yet"},{"tier":"federal_only","label":"Federal layer only"},{"tier":"pending","label":"Pending review"},{"tier":"not_surveyed","label":"Not surveyed yet"}],"pricing":{"currency":"usd","free_trial":{"scans_per_asset_type":1,"label":"First check is on us","blurb":"One free scan of each asset type: an email, a landing page, a blog post, and a social post."},"token_packs":[{"key":"pack_10","label":"10 tokens","tokens":10,"price_cents":1900,"blurb":"Pay as you go. One token, one scan, any asset type. Tokens never expire, and there is nothing to cancel."}],"bus_passes":[{"key":"bus_pass","label":"Bus Pass","scans_per_period":500,"period":"month","price_cents":9900,"annual_price_cents":99000,"per_client":false,"min_clients":null,"scans_per_client":null,"blurb":"For one practice or one in-house team. Check every piece you ship instead of rationing checks. The 500 a month is a fair-use ceiling, not a budget: a busy desk runs a few dozen. Every ruleset, the advanced rewrite, cancel anytime."},{"key":"agency_pass","label":"Agency Pass","period":"month","price_cents":2500,"annual_price_cents":25000,"per_client":true,"min_clients":5,"scans_per_client":150,"blurb":"For a roster, not a desk. $25 per client per month, five client minimum, priced in the unit you already bill in. 150 scans per client pooled across the whole team, the append-only compliance log, your own name and logo on the client-facing report, and priority on ruleset requests for the states and verticals you work in."}],"video":{"tokens_per_started_30s":1,"min_tokens":2,"max_seconds":180,"blurb":"Video creatives cost 1 token per started 30 seconds, 2 token minimum, priced before you confirm. Time-coded findings, same rulesets, plus the video disclosure pack."}}}